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Lipids are essential components to all known life.  They serve m any functions from basic build-
ing blocks to covalent protein modification and are particularly involved in signaling. Many rare 
and widespread human health concerns involve lipids but despite their importance, their analysis 
either free or protein-bound has rem ained difficult for decades. Here, us ing bioorthogonal chem-
istry, we have developed a robust system  to identify the proteins m odified by lipids and ad-
vanced the ability to image cholesterol in cells and tissues. 
 
The unbiased proteom ic analysis of fatty-acylate d proteins using chem ical reporters undertaken 
here revealed a greater diversity  of lipid-m odified proteins in mammalian cells than had pr evi-
ously been appreciated. Proteins  targeted by  a series of fatty acid ch emical reporters rangin g 
from myristic to stearic acid showed their involvement in a vast range of cellular processes from 
all cellular com partments. Many nuclear proteins we re found, in particular histone H 3 variants. 
Histones H3.1, H3.2 and H3.3 were demonstrated to be modified with fatty acid chemical report-
ers on the conserved cysteine 110, a novel site of S-acylation on histone H3.2. This newly dis-
covered modification of histone H3 variants could have implications for nuclear organization and 




Cholesterol is an abundan t sterol in the m embranes of higher  eukaryotes that is important in 
mammalian physio logy and d isease. This  ancient lipid serves m ultiple ess ential functions in 
membranes and signaling, but the precise m echanisms of its trafficking and function as a protein 
PTM remain to be f ully elucidated. The m ultiple techniques developed to visua lize cholesterol 
often give conflicting results and can inaccurately depict cholesterol distribution due to structural 
perturbations of analogs or stai ning specificities. Here, using cl ick chemistry, we developed the 
fluorescent visualization  of c holesterol protein modification and cholesterol trafficking in vivo 
with 25-azidonorcholesterol (az-chol). Az-chol exhibits minimal structural perturbation, is cova-
lently attached to proteins, incorporates into membranes like cholesterol, faithfully detects altera-
tions in lipid trafficking and reveals an asymm etrical cholesterol distribution in the brain of the  
developing mouse em bryo. The bioorthogonal chem ical reporter az-chol provides a new, sensi-
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INTRODUCTION: LIPIDS AND THEIR STUDY 
 
Lipids are essential components of all cells that are unique in their ability to self-assemble, or-
ganizing through membrane segregation. They are also unique in their heterogeneity: the lip-
idome of yeast exhibits several hundred species1 and hundreds of thousands of variant exist with-
in biology1. Matching their biological importance, lipid binding domains are among the most 
common modular domains of the eukaryotic proteome2. In health, alterations of lipid metabolism 
can lead to diseases as common as cardiovascular disease and obesity, as well as rarer disorders 
such as Niemann-Pick or Tay-Sachs Diseases. Despite this importance, lipid analysis remains 
challenging and progress in analytical techniques is greatly needed.  
Lipid function 
Free lipids 
Lipids and their derivatives function in a vast array of cellular functions. In membranes, they are 
the primary building block, with different membranes exhibiting remarkable compositional vari-
ation. Localized membrane domains are important in signaling and other processes such as ca-
tabolism and photosynthesis. In metabolism, lipids serve not only as energy storage but also as 
essential vitamins for many organisms. Some, like the eicosanoids (leukotrienes and prostaglan-
dins)3 and diacylglycerols are signaling molecules, while others such as sterols serve multiple 
roles as signaling molecules, nutrient and membrane components. Lipids play a role in all cellu-
lar processes from the cell boundary to the catalytic center of some enzymes. 
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Covalently protein-bound lipids 
Lipids are a covalent post-translational modification (PTM) on proteins where they serve to 
modulate protein localization, activity and signaling. This occurs for a variety of lipids (see Fig-
ure 1) including fatty acids (caprylic4, myristic, palmitic and stearic acids and others) on their N-
termini, cysteines, serines, threonines or lysines; isoprenoids (farnesol and geranylgeraniol and 
dolichol) on cysteines; and cholesterol and glycosylphosphatidylinositol on processed C-termini. 
These post-translational modifications (PTMs) play important roles in eukaryotic physiology and 
human disease5. Lipid modification of proteins typically increases their affinity to membranes 
and subsequent interaction with other proteins for cell signaling5,6 (Figure 2). Biologically, 
known fatty-acylated proteins have wide-ranging roles in cellular proliferation (Ras), lympho-
cyte activation (Lck) and synaptic transmission (PSD-95)5, among many others. N-myristo-
ylation and S-palmitoylation in particular compromise two major mechanisms of protein lipida-
tion by which eukaryotic cells control protein activity spatially and temporally5. Partially due to 
prior limitations in analytical techniques, much remains to be understood about the diversity of 
lipidated proteins and the mechanisms of their regulation5. This research is further complicated 
by the actions of other PTMs which simultaneous affect the activity of lipid modified proteins. 
For example, phosphorylation and fatty-acylation work in concert to regulate the activity of 











N-Myristoylation is a constitutive cotranslational modification in which myristic acid (14:0) is 
attached to N-terminal glycine residues through the action of N-myristoyltransferases (NMTs)11. 
It can also occur post-translationally after proteolytic events which expose new NMT recognition 
sites. For example, during programmed cell death, the apoptosis effector tBid is N-myristoylated 
after cleavage by caspase-3, resulting in mitochondrial membranes localization during apopto-
sis12,13. Alternative splicing of mRNA transcripts may also yield substrates for N-myristoylation, 
as with the p35 isoform of OCA-B, a transcription factor required for late-stage B cell develop-
ment14,15. 
 
Figure 2 Cellular pathways involving lipid PTMs. 
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Palmitoylation denotes the addition of palmitic (16:0) and other fatty acids onto proteins, most 
commonly onto a cysteine thiol side chain (S-acylation) although other residues including the N-
terminus can be modified16,17. The terms “palmitoylation” and S-acylation are commonly used 
interchangeably to indicate modification not exclusive to palmitic acid. The modification is bi-
ased to palmitic acid but includes a heterogeneous mix of fatty acids both longer and shorter 
which can also vary in degree of saturation and oxidation. Stearate (18:0), oleate (18:1), arachi-
donate (20:4), and eicosapentaenoate (20:5) have all been shown to be incorporated onto pal-
mitoylated proteins18,19. The thioester bond of S-acylation can be cleaved by hydroxyl amine; this 
sensitivity is often used to distinguish fatty acylation of cysteine from N-terminal modification. 
Palmitoylation can occur enzymatically, through a conserved family of Asp-His-His-Cys-
containing protein acyltransferases (DHHC-PATs)20, or by autocatalytic mechanisms intrinsic to 
a protein. Palmitoylation is unique in its reversibility with two thioesterases known to depal-
mitoylate. Dissecting the regulatory mechanisms of palmitoylation presents a significant chal-
lenge as the 23 DHHC-PATs of humans or mouse exhibit overlapping substrate specificities and 
have no known consensus sequence21. Predictive algorithms based on known sites do exist, but 
with unknown sensitivity and specificity outside of their training set22. 
 
Isoprenoid modification, in particular farnesylation and geranylgeranylation, is an irreversible 
post translational event which occurs at cysteines in the C-terminal region. One farnesyltransfer-
ase (FTase) and two geranylgeranyltransferases (GGTase-I and GGTase-II) can transfer one or 
more isoprenoid moieties to C-terminal cysteines yielding thioether bonds23-25. FTase and 
GGTase-I recognize the consensus sequence CaaX in which a is aliphatic the residue X deter-
mines modification by FTase (A, C, M, Q or S) or GGTase-I (L or F). GGTase-II has no known 
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consensus sequence23-25. Like other lipidation events, isoprenylation causes membrane targeting 
and mediates protein-protein interactions23-25. 
 
Protein cholesterylation is currently 
only known in the hedgehog family 
of secreted signaling molecules. Its 
function is known on Sonic hedge-
hog (Shh), where it restricts the spa-
tial diffusion to generate the mor-
phogen gradients controlling verte-
brate development26,27. Cholesterol 
is installed by an autocatalytic pro-
cessing event of the 45 kDa Shh 
precursor in which an internal G-C 
bond in an absolutely conserved 
GCF tripeptide first undergoes an 
autocatalytic N to S shift within the 
so called Hedgehog/intein (Hint) 
domain28, a motif so named due to sequence, mechanistic and three-dimensional structure simi-
larities between inteins and hedgehog protein autoprocessing domain (see Figure 3). The thiol 
side-chain of cysteine of the GCF tripeptide nucleophilically attacks the carbonyl carbon of G, 
forming an activated thioester intermediate. Subsequently, the intermediate undergoes a nucleo-
philic attack by cholesterol and the covalently cholesterylated 19 kDa N-terminal portion of Hh 
Figure 3 Mechanism of cholesterylation in Shh. 
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is released. All biological activity is associated with this N-terminal fragment. Cholesterylation 
null mutants show gross mispatterning and embryonic lethality in Drosophila embryos and muta-
tions in humans result in holoprosencephaly27. 
 
Glycosylphosphatidylinositylation has the most complex structure of lipid PTMs consisting of a 
phosphoethanolamine linker to the protein, a glycan core, and a phospholipid tail29. GPI-anchor 
modification results in localization to the outer leaflet of the plasma membrane and occurs within 
a wide variety of biological processes29. The exact structure is heterogeneous and species de-
pendent but like cholesterylation, GPI anchors are installed during a proteolytic event. A GPI-
transamidase complex recognizes a C-terminal GPI anchor attachment signal with no known 
consensus sequence and cleaves the signal at the so named omega (ω) site30. A preassembled 
GPI core structure is subsequently attached covalently to the nascent C-terminus30. Animals de-
fective in glycosylphosphatidylinositol modification die as embryos29. 
Lipid analysis 
Despite their significance, lipids analysis on or off proteins has for decades remained difficult. 
Progress in chromatography over the last five decades – in particular thin layer chromatography 
(TLC) and gas-chromatography (GC) – opened the doors to lipid separation and identification1. 
This trend has been built upon by advances in mass spectrometry, in particular matrix assisted la-
ser desorption ionization (MALDI)31 and electrospray ionization (ESI)32. While powerful, these 
advances are typically applicable only after lipid extraction and often hydrolysis. Deciphering 
biological function requires identifying what lipids are where within cells, when, and their in-
teractors. A host of techniques have thus been developed for lipid analysis. Strategies for indirect 
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detection include hydrophobic and fluorogenic membrane dyes (e.g. DiI33, filipin or 1,6-
diphenyl-1,3,5-hexatriene, DPH); lipid-binding proteins either internally expressed or externally 
applied (lipid binding domains fused to fluorescent proteins34 or chemically conjugated proteins; 
a few antibodies also exist); linked enzymatic assays (e.g. cholesterol oxidase) and chemical 
tools to manipulate lipid levels such as cyclodextrins. Caution must be used with indirect tech-
niques as they have varying degrees of sensitivity to external factors such as membrane composi-
tion or lipid accessibility. In addition, indirect techniques may suffer issues of selectivity, com-
monly interacting with more than one lipid. Alternatively, lipids may be directly detected direct-
ly with three different varieties of analogs (Figure 4). 
Analysis with radioactivity 
The oldest technique for lipid analysis involves radioactive molecules and autoradiography. Fatty 
acids35, cholesterol36 or isoprenoids, or lipid precursors37, in particular acetate, pyruvate and 
mevalonate, can be incorporated both in vivo or in vitro. This approach can reveal lipid localiza-
tion in tissue slices38, image lipidated proteins within SDS-PAGE gels39 or be used to track lipi-
dated proteins through chromatographic separations. For ultra-high resolution imaging, autoradi-
ographic visualization can also be combined with electron microscopy (EM)40. Due to their iden-
tical chemical nature, radiolabeled reporters most faithfully recapitulate true biological behavior. 
However, the approach cannot be easily combined with other common analyses such as im-
munohistochemistry (IHC). It also suffers from long exposure times (often weeks to months, 
precluding live autoradiography) and the disadvantages of radioactivity. Detection times can be 
substantially reduced with the use of 125I iodinated lipids41, but at the cost of changes in structure, 
additional health exposure and regulatory overhead. 
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Analysis with analogs 
The second and third variations of direct imaging involve chemically modified lipid analogs. 
Fluorophore-conjugated lipids42-45 allow immediate imaging of lipids from proteins to organ-
isms. Many fluors have been employed including BODIPY46,47, NBD48-50, dansyl51-53, rhoda-
mine54, anthracene55,56, pyrene57-61, DPH62, naphthyl63 as well as others. Likewise, lipid analogss 
bearing photochemical crosslinking groups64 can be employed to assay lipid interactions. To en-
able detection, crosslinking analogs typically contain an additional mark such as radioactivity, an 
affinity handle or fluorophore. While useful tools, both analog variations are intrinsically limited 
by the alteration of relatively small lipids44. Added fluorophores are often larger than the mole-
cules to which they are fused and can greatly alter essential properties such as hydrophobicity 
and charge. These changes can result in altered biological behavior44,65 such as lipid sorting by 
differential partitioning66,67 or endogenous lipid recognition. For example, NBD-cholesterol has 
been shown to orient itself “up-side-down” with the 3β-hydroxyl pointing into the membrane68 
and with other BODIPY-69 and NBD-labeled50 lipids, fluors exist “looped back,” preferring the 
surface rather than the membrane interior, apparently in reflection of additional polarity. Such in-























Analysis with intrinsically fluorescent analogs 
Intrinsically fluorescent lipids such as the dehydroergosterol (DHE)70-73 or polyenes like the nat-
urally occurring cis-parinaric acid74, pentaene-carboxlic acids75,76 or didehydrogeranylgerany77 
provide more faithful fluorescent reporters. However, DHE and parinaric acid suffer from low 
quantum yield, rapid bleaching and ultra-violet (UV) excitation and emission, thus necessitating 
specialized, UV-transparent imaging equipment78. Conjugated pentaene analogs are sufficiently 
red-shifted to allow imaging with standard optics, but still suffer from rapid photobleaching and 
require two-photon excitation to minimize fluorophore damage75. These non-ideal photochemical 
Figure 4 Classes of marked or modified lipids. Fluorescent (A)
or tagging (B) modifications can cause large perturbations in bi-
ological or chemical behavior. Radiolabeling (C) suffers from
long exposure times, but are the most faithful analogs. 
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properties often compel cellular loading with reporter concentrations sufficiently high that atypi-
cal pathways may be preferred79. In addition, while autoflorescent analogs maintain more struc-
tural similarity than analogs fused to fluorophores, even subtle alterations such as the presence or 
absence of a methyl group80,81 or cis versus trans stereochemistry82,83 can significantly alter bio-
logical function. Indeed, the additional rigidity imposed by conjugated desaturation has been ob-
served to modify both membrane structure and biological behavior: DHE disturbs membrane li-
pid packing density at concentrations of >1 mol%68 and is esterified >7-fold more rapidly than 
[3H]cholesterol84; parinaric acid remains essentially unesterified in fibroblasts83 and can be cyto-
toxic85; and didehydrogeranylgeranyl is incorporated 60% as effectively as geranylgeranyl77. 
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BIOORTHOGONAL CHEMICAL TECHNIQUES 
 
The disadvantages of indirect labeling (dependence on multiple factors and accessibility) and di-
rect labeling (alteration of properties) can be circumvented by directly marking the molecule of 
interest with a small, specifically reactable chemical handle which causes minimal alteration in 
cellular behavior. In this bioorthogonal strategy, the third strategy using analogs, reporter mole-
cules are first metabolically incorporated, allowing proper metabolism and localization. Subse-
quently, the chemical handle is interrogated to covalently add tags for visualization or affinity re-
trieval. These are typically fluorophores, some of which are fluorogenic, or common affinity tags 
such as biotin, which can be probed with Western blots or used in affinity retrieval. Especially 
for lipids, it must be noted that the advantage of similar biochemical behavior is likely abrogated 
after addition of visualization tags. The application of bioorthogonal chemistry to live lipid anal-
ysis86 thus necessitates great attention to behavior before and after analog modification. Table 1 
contrasts bioorthogonal approaches with intrinsically labeled molecules. 
 
Bioorthogonal techniques require unique constraints within chemical reaction space and have on-
ly recently been introduced. The reaction must occur in cellular environments (i.e. at physiologi-
cal temperature and pH within aqueous solutions containing salts, nucleophiles and oxygen); it 
must be highly specific, not reacting with the functional groups present in cells; it must proceed 
efficiently at very low concentrations; the reaction must occur in a biologically relevant time 
frame (seconds to hours); it must be irreversible; and the chemical handle must be biologically 
inert (bioorthogonal): it must not be metabolized by the cell, not present within the cell, nor alter 
cellular recognition or metabolism. These very specific bioorthogonal needs have been best met 
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Table 1 Contrasting properties of bioorthogonal probes and tagged analogs. 
 
Attribute  
    
Tagged molecules  
Size Small change Usually much larger (excepted by intrinsically fluorescent analogs) 
Hydrophobicity Very little difference Similar to very different 
Charge No change Same to reversed charge 
Overall chemical 
similarity 
Generally similar to native mole-
cules (but substantially altered after 
click reaction)  
Generally different 
Live imaging  Limited; usually stepwise or cell ex-terior  Usually possible (tag dependent)  
Biocompatibility Tolerated as part of an organic mol-ecule Tag dependent 
Orthogonality Absent (N3) and infrequent (–≡) 
Usually absent (although autofluo-
rescence or pigments can interfere) 
Reaction specificity  Specific with low background  No reaction after incorporation  
Modularity Highly modular Limited 
Synthetic accessi-









The Staudinger reaction 
Bioorthogonal chemistry was pioneered by the Staudinger reaction in 2000 by Bertozzi and 
coworkers, who employed the selective reaction between a modified phosphine and an azide in 
biological conditions87. Through rearrangement of an aza-ylide intermediate, a stable amide bond 
results between the oxidized phosphine reagent and the azide bearing analog (Figure 5). Due to 
the phenylated phosphine size and hydrophobicity, analogs employed for bioorthogonal chemis-
try using the Staudinger reaction carry an azide. In the original application, metabolic incorpora-
tion of N-azidoacetylmannosamine (ManNAz) in HeLa and Jurkat cells labeled surface glycans, 
which were then reacted with a biotin derivatized phosphine and visualized with fluorescent avi-
din. The reaction has been further expanded by the development of a “traceless” version, in 
Figure 5 Bioorthogonal chemistries in various applications. 
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which amide bonds are formed with exit of the phosphine88. Multiple phosphine reagents have 
been developed including fluorogenic dyes which remain quenched until reacting including a 
coumarin derivative89 and a fluorescein compound90 initially silenced by a fluorescence reso-
nance energy transfer (FRET). The phosphines have a distinctive smell but are not particularly 
toxic and have been applied to live cells90,91 and in mice92. Within lipids, the Staudinger reaction 
has since been applied to fatty acids93-99, isoprenylation100-105, targets damaged by lipid peroxida-
tion106, gangliosides107 and ceramide synthesis108. Despite the large body of work, the reaction 
suffers from relatively slow reaction kinetics and sensitivity of the phosphine to air oxidation109. 
Unfortunately, success in improving phosphine reactivity also increased rates of oxidation109 and 
other bioorthogonal chemistries have been consequently sought. 
Click chemistry and CuI-catalyzed [3+ 2] azide-alkyne cycloadditions (CuAAC) 
Shortly after the biological application of the Staudinger reaction, in 2002 Meldal and cowork-
ers110 as well as Sharpless and coworkers111 discovered that copper(I) can catalyze Huisgen az-
ide-alkyne cycloadditions to give 1,4-disubstituted 1,2,3-triazoles (Figure 5). The reaction pro-
ceeds in aqueous conditions at room temperature rapidly with high yield and was illustrated on 
proteins, nucleic acids and sugars. The field of CuI-catalyzed [3+ 2] azide-alkyne cycloadditions 
(CuAAC) has since exploded112-114 with applications of terminal alkyne and azide analogs ap-
plied to all classes of biological building block. While it is only one of a family of reactions ex-
hibiting the modular philosophy and properties of “click chemistries,”115 the ease and widespread 
applicability of Huisgen azide-alkyne cycloaddition have lead it to it commonly being known by 
the “click chemistry” moniker. The cycloaddition was advanced by the development of copper 
ligands that increase reaction kinetics catalyst stability116,117 and CuAAC has been applied to fat-
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ty acids94,96-98,118-123, isoprenoids, cholesterol124, choline125, phospholipids86 and azido diacyl-
glycerol (DAG)126. Despite its utility, the metal-catalyzed cycloaddition remained limited by the 
requirement of cytotoxic copper which prevented live imaging that remained possible using the 
Staudinger reaction. 
Strain promoted alkyne-azide cycloadditions (SPAAC) 
Consequently, in 2004 Bertozzi and coworkers developed a copper-free version of azide-alkyne 
cycloaddition catalyzed by the strain of a cyclooctyne127 (Figure 5), the smallest stable cycloal-
kyne, and illustrated its use again on glycans128. Strain-promoted alkyne-azide cycloaddition 
(SPAAC) generates the same triazole ring and has been further developed with more stable and 
more reactive cyclooctyne derivatives129-131. The lack of copper lends it particularly well to in vi-
vo imaging and the strategy has been applied to live visualization of a phosphatidic acid ana-
log132 and to surface proteins bearing azido caprylic acid (Az-8)133. 
Considerations in choice of bioorthogonal chemistries and reaction pairs 
Owing to its fast kinetics, CuAAC has been found to be more rapid and sensitive in the detection 
of bioorthogonal probes129 and in particular with lipid analogs94,97. Both the Staudinger reaction 
and SPAAC can both be used in live imaging to circumvent copper toxicity, although the stabil-
ity of reagents in click chemistry reactions increases its appeal. In click chemistry, reacting al-
kyne analogs with azido probes produced a lower background than the respective reaction with 
azido analogs and alkyne probes94,134,135 but the side products remain unknown. Many SPAAC 
reagents are exceedingly hydrophobic and we have found them poorly suited to work on cell in-
teriors or permeabilized cells: they tend to function as dyes rather than reagents which can be 
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washed away. Fluorogenic reagents, in particular coumarin derivatives, are appealing possible al-




The biology and chemical properties of bioorthogonal handles 
Both click chemistry and the Staudinger reaction employ azides and many analogs modified ei-
ther with an azide or alkynes have been synthesized and employed (Table 1 and sections below). 
As for all modified molecules, consideration must be given to their possible biological presence, 
their potential biological activity and the possibility for change in alterations in chemical behav-
ior. 
The azide in biology 
The azido group is unique within organic chemistry for its ease of introduction and reactivity. 
Azides are typically added with well-established nucleophilic substitution or azo transfer reac-
tions and can be substituted for a methyl. As an anion, the azide displays toxicity similar to cya-
nide and, perhaps consequently, is virtually non-existent within biology136: exactly one azido 
containing product from a dinoflagellate137 is listed in the Natural Products Dictionary and 2-
amino-3-azidopropanoic acid can be produced by Salmonella in the presence of azides138. In con-
trast, synthetic organic azides have for decades functioned as photolabile probes64 and appear to 
be biologically well tolerated: 12-Az-12 causes no cellular toxicity in CEM cells139 and multiple 
azido-derivatized fatty acids support the growth of E. coli140,141, pseudomonad142 and S. cere-
visiae143 fatty acid auxotrophs. In our own work, we have not observed toxicity of azido fatty ac-
ids up to 100 µM in Jurkat, HeLa, RAW and DC2.4 cells. However, caution must always be used 
as toxicity of azido derivatized sugars has been observed144, 12-Az-12 was found to be an inhibi-
tor of HIV replication139 and it inhibits mitochondrial phosphate uptake at 100 µM145. Likewise, 
organic azides are part of four bioactive, FDA approved drugs (3′-azidothymidine, an anti-HIV; 
Azidocillin and Azidamfenicol, antibiotics; and zidometacin, an anti-inflammatory). Metabolism 
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of aryl azides has been observed in yeast143 and the reduction of aryl azides to amines was seen 
after ex vivo exposure to mouse liver microsomes146. 
The alkyne in biology 
Contrasting the biological absence of azides, alkynes are found in a large diversity of natural 
products from fungi, moss and lichens, plants, marine algae, tunicates, sponges, insects, frogs 
and in traces quantities, even in mammals147. Plants, mosses and fungi in particular can accumu-
late high concentrations of alkynyl lipids, and, of the >2000 polyacetylenes known, more than 
1100 are found in the plant family Asteraceae (the aster or sunflower family)147. Acetylenic 
groups are found both internally and at molecule terminals148,149. Both natural and synthetic al-
kyne lipids have been shown to have anticancer148, antibacterial, antifungal, anti-HIV and pesti-
cidal activities150. Several alkyne-containing compounds, including ethynylic steroids, are ap-
proved drugs and various acetylenic compounds are known to inhibit monoamine oxidases A and 
B, aromatase, cytochrome P450 isozyme families including 1A, 3A and 22A, and thymidylate 
synthetase151. Others serve as cholinergic and muscarinic agents151. Terminal alkyne compounds, 
in particular 17-octadecynoic acid (ODYA) or alk-16, are known irreversible mechanism-based 
inhibitors of plant152 and mammalian153-155 fatty acid ω-hydroxylases, as well as P450 hydroxyl-
ases156,157. Alk-16 is unable to support growth of unsaturated fatty acid auxotrophs of E. coli or 
S. cerevisiae although the fatty acid was found in membranes and could be esterified158. The 
equivalent experiment with saturated fatty acid auxotrophs was not performed, however the 
myristic acid analog alk-12 is a better substrate for S. cerevisiae N-myristoyl transferase than 
myristic acid159. In our hands, with Jurkat, HeLa, RAW and DC2.4 cells, alkyne fatty acids up to 
100 µM show the same overt lack of toxicity as azido fatty acids but we did not examine possi-
20 
 
bly inhibited enzymes. Synthetic acetylenic analogs can be made through synthesis of an analog 
desaturated at a terminal secondary-primary carbon pair, or by the addition of an ethynyl to an 
accessible atom. Alkyne synthetic schemes can be more complicated than their equivalent azides 
due to the requisite alteration in carbon-carbon bonds, although not necessarily, as an ethynyl 
might also be added to a heteroatom. 
Chemical properties of azides and alkynes 
Like the cyano (–C≡N), the atoms of acetylene (–C≡CH) and azido (–N=N+=N-) groups exist 
within a π electron rich cylinder. An acetylene group attached to a carbon forms a linear array of 
four atoms which emanate at the angle of the originating carbon hybridization; azides in contrast 
are bent slightly off axis with a C-N1 angle of around 120°. Due to the linear alignment, the dis-
tance from a terminally ethynylated carbon to the final hydrogen of the acetylene (3.72 Å) is ac-
tually longer than the corresponding maximum distance of an ethylated carbon to one of its ter-
minal hydrogens (3.06 Å) despite the shorter carbon-carbon bond (1.21 Å vs. 1.54 Å). For lipids, 
this linear “kink” and its position can have significant implications for enzyme recognition159 and 
membrane function: only three of 16 isomers, 7-, 8- and 10-octadecynoic fatty acids, can support 
growth of an S. cerevisiae unsaturated fatty acid auxotroph158. Unlike ethynyl groups, azides are 
mostly – but not perfectly – linear, and must be terminal, while alkynes can exist within a hydro-
carbon chain. In length, azides are shorter than an ethynyl group yet still slightly longer than an 
ethyl group (3.29 Å from the azido bearing carbon to the last nitrogen). Both functions are rela-
tively nonpolar: the dipole moment for phenylazide (C6H5-N3) is 1.44 D and for phenylacetylene 
(C6H5–C≡CH) 0.66 D160; these values contrasts to benzonitrile (C6H5–C≡N) at 4.05 D. Both 
groups have a similar effect on water solubility: at 25 C, phenylazide is soluble to 4.2 mM161 and 
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phenylacetylene to 4.46 mM162 (these values contrast with benzene at 22.1 mM163). The molecu-
lar volume of both functional groups is small: the conformational preference (–∆G°) for the 
equatorial position of cyclohexane is 1.70 kcal/mol for a methyl (–CH3); 1.75 kcal/mole for an 
ethyl (–CH2–CH3); 0.48 ± 0.07 kcal/mol for an azido164; and 0.41 ± 0.05 kcal/mol for an acety-
lene group165. 
 
Thus, azides and acetylenes are around the length of an ethyl group (and are both linearly longer) 
but occupy less volume and are rigid. They are more polar, but not drastically so, and more reac-
tive, though stable under typical physiological temperatures and solvent conditions (aqueous so-
lutions around neutral pH containing many dissolved salts and other substances). Neither adds 
charge and they are usually biologically stable. However, both stability and unexpected biologi-
cal effects should be studied; the careful controls required to exclude side-effects remains unex-
amined for many published analogs. Alkynes and azides thus offer a good opportunity to faith-




Bioorthogonal lipid probes 
A wide variety of alkyne and azide probes have been described for many lipid classes. In particu-
lar, owing to their synthetic accessibility and utility in photocrosslinking, a wide variety of azido 
(especially aryl-azide) lipid analogs have been published. For decades, they have been employed 
to identify lipid-binding proteins or membrane domains. Reported azide and alkyne lipid analogs 
include saturated and unsaturated fatty acids, isoprenoids, glycosides, 4-hydroxynonenal (HNE, a 
byproduct of unsaturated lipid peroxidation) sterols and sterol derivatives, sphingosines, 
ceramides and diacylglycerol. However, only a few have been subsequently utilized in 
bioorthogonal chemical investigations. In those cases, frequently a corresponding alkyne has 
been synthesized due to background labeling issues. The pair also serves as an internal control, 
similar to N- and C-terminal tagging with fluorescent proteins. 
Probes for fatty acids 
Azido and alkyne fatty acid probes from 10 to 18 carbons in length have been described and em-
ployed using both the Satudinger reaction and CuAAC with fluorescent and Western blot detec-
tion (see Table 2). The relative activity of az-12 and alk-12 was previously studied in depth for S. 
cerevisiae NMT (~140% and ~100%-120% relative to myristic acid, respectively139,159) and sub-
sequent studies have employed well studied, known fatty-acylated proteins such as 
Lck93,94,119,120, various forms or fusions of Ras94,118,119, LAT94,119 GAPDH118,119 to validate proper 
incorporation. Direct comparison of alkyne and azido analogs of myristic acid (alk-12 and az-12) 
as well as stearic acid (az-15 and alk-16), revealed very similar incorporation profiles indicating 
that the orientation has little influence on cellular recognition of fatty acids94. In contrast, work to 
isolate palmitoylated mitochondrial proteins revealed a large discrepancy between iodopalmitoyl 
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CoA and az-1495, indicating that the large halogen alters cellular processing. As described below, 
these probes have been applied to visualizing fatty acids in membranes and on proteins, as well 
in discovering the identity of fatty-acylated proteins. 
Probes for isoprenoids 
Geranyl103,105,166, farnesyl101,105,167 and geranylgeranyl102,168 analogs have been described in both 
azido and alkyne varieties (see Table 3). FTase and GGTases can show both substrate toler-
ance100 and specificity, allowing some degree of control over the prenyl analog incorporation104. 
In contrast to fatty acid probes, several analogs incorporate hetero atom changes in their back-
bone; despite the change in hydrophobicity, this alteration seems to be well tolerated such as for 
alk-FFP and Alk-GPP1166,167, though not always, as in the case of GPP2, which was ineffective 
at displacing the natural substrate100. 
Probes for other lipids 
A propargyl analog of choline125 and analogs of phosphatidic acid132 have also been described 
(See Table 4). Metabolic labeling with propargylcholine resulted in biosynthetic incorporation 
into phospholipids which were incorporated into expected classes of lipids in CHO cells with 
similar efficiency to choline125. The three phosphatidic acid analogs include a cyclooctyne deriv-
ative which allowed live visualization of membranes in cell culture using a fluorogenic coumarin 
azide132 but no comparison of analog with native phosphatidic acid. The phosphate of all analogs 
was capped with a S-acetylthioethyl group (SATE) which is rapidly cleaved in living cells by es-




Table 2 Bioorthogonal probes of fatty acids and their applications 
 
Structure Probe 



















































































Alk-9  x X     x    Visualization of protein short chain acylation in PC3 cells 121 
O
OH













 x x   x x x x x  Visualization of protein myristoylation in multiple cell lines and myristic acid in HeLa cell membranes
94 
 x x   x  x  x  Visualization of protein myristoylation in PC3 cells 121 
 x x    x x    NMT-mediated tagging of overexpressed proteins in E. coli 97 
 x x   x x x    
Visualization of protein myristoylation in Jurkat cells with 
and without apoptosis and COS-7 cells overexpressing EGFP 
fusions 
118 
 x x   x x x x  x Large scale ID of myristoylated proteins and their validation in fully solubilized Jurkat cells 
119 
 x x   x x  x   Determination of palmitoylation turnover in Jurkat cells 120 
O
S CoA






N3  Az-12 
x  x   x x     Visualization of protein myristoylation in RAW264.7 cells 93 
x x x   x x x x x  Visualization of protein myristoylation in multiple cell lines 94 
x  x   x x x    Visualization of myristoylation on proteins predicted to be post-translationally modified during apoptosis 
96 





 x x   x  x x   Visualization of protein myristoylation/palmitoylation in multiple cell lines 
94 
 x x     x  x  Visualization of protein myristoylation/palmitoylation in PC3 cells 
121 
 x x   x x x x  x Large scale ID of myristoylated/palmitoylated proteins in ful-ly solubilized Jurkat cells their validation 
119 
 x x   x x x    
Visualization of protein myristoylation/palmitoylation in 
Jurkat cells, COS-7 cells overexpressing EGFP-Ras fusions 
and RAS IPed from mice 
118 





 x   x       NMT-mediated tagging of peptide 97 




N3  Az-14 x  x   x  x    







 Az-14-CoA x   x x   x    
Identification of mitochondria protein palmitoylation through 





x  x   x x     Visualization of protein palmitoylation in RAW264.7 cells 93 
x x x   x x x x x  Visualization of protein palmitoylation in multiple cell lines and stearic acid in HeLa cell membranes 
94 







 x x   x x x x x  Visualization of protein palmitoylation in multiple cell lines and stearic acid in HeLa cell membranes 
94 
 x x   x  x  x  Visualization of protein palmitoylation in PC3 cells 121 
 x x   x   x  x Large scale ID of palmitoylated proteins from Jurkat cell membranes and their validation by overexpression 
122 
 x x   x x x x  x Large scale ID of palmitoylated proteins and their validation in fully solubilized Jurkat cells 
119 
 x x   x x  x  x Large scale ID from DC2.4 dendritic cells 123 
 x x   x x  x   Determination of palmitoylation turnover in Jurkat cells 120 
O
OH






























































































Az-FPP1 x  x  x x  x  x 
Visualization of farnesylation in COS-1 cells and identification of 18 modified 
proteins 
101 
x   x   x    N-terminal geranylation of peptide by FTase 105 
Az-F-OH x  x     x  x Visualization of farnesylation in COS-1 cells and identification of 18 modified proteins 
101 
Az-GPP x   x   x    N-terminal geranylation of peptide by FTase 103,105 
Az-GPP1 (APO-GPP) x   x  x x   x Geranylation of peptides and proteins by FTase. 100 
Az-GPP2 (AAA-GPP) x   x  x x   x Geranylation of peptides and proteins by FTase. 100 
Az-GG-OH  x x  x    x  Identification of geranylgeranylated proteins through 2D gel separation and iden-tification 
102 
 x x  x    x  Visualization of geranylgeranylated proteins  168 
Az-GGPP  x  x     x  Visualization of geranylgeranylated proteins in HEK293A and mouse tissue cells 104 
Alk-GPP  x    x     Geranylation of eGFP for FRET between added fluorophore 166 
Alk-FPP1  x  x     x  C-terminal farnesylation for subsequent covalent attachment  167 








Table 4 Probes for other lipids. 
 
Probe In vivo CuAAC SPAAC Application Ref. 
Alk-Cho 
X X  Imaging choline phospholipids in 
CHO cells and mice. 
125 
Alk-PA1 X X  
Imaging lipid distribution in cells. 
132 
Alk-PA2 X X  132 
Calk-PA X  X 132 
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Applications of lipid bioorthogonal chemical reporters 
Visualization of lipids in membranes 
The application of bioorthogonal chemistry to the study of lipids in cells and their membranes is 
one of the most promising advances in lipid imaging. The Staudinger reaction and click chemis-
try allow work with stable, nonradioactive lipid analogs with high sensitivity which do not suffer 
the disadvantages of bulky fluorophores and which are relatively unperturbed. Likewise, the 
need for specialized UV transparent microscopes is negated and analysis is made both accessible 
and rapid. This approach has been applied to myristic and stearic acids, imaged with rhodamine 
addition by CuAAC in HeLa cells revealing strong, detergent (0.1% triton X-100) and methanol 
sensitive membrane labeling94. 
 
Propargyl choline was imaged in CHO cells and in mice125. In both cases, membrane structures 
such as the plasma membrane were clearly labeled125. The use of regents of different cell perme-
ability (fluorescently tagged streptavidin and Alexa Fluor 568) also allowed distinction between 
surface and internal analog125. As for fatty acids, choline analog did not colocalize with any one 
subcellular markers in CHO cells125, likely a reflection of the complex composition of cellular 
membranes and their fast diffusibility. Supporting techniques used to analyze lipid rafts, different 
detergents had marked effects on labeled lipid: tween-20 does not alter the signal of fatty acid 
analogs94, but triton X-100 is sufficient to remove membrane signal completely for fatty acids or 




Phosphatidic acid imaging by the three different reporters yielded similar images in RAW cells 
whether by CuAAC after fixing or by live imaging SPAAC with the cyclooctyne. The reporters 
remains membrane bound after reaction in live cells, however no further study was done to de-
termine the effect of reaction132 and the subcellular localization of any analog has not yet been 
examined. 
Visualization of lipid PTMs on isolated proteins 
Bioorthogonal chemistry provides a convenient and nonradioactive alterative to determine if a 
particular protein of interest is lipidated both in vivo and in vitro. Purified proteins can be modi-
fied in reconstituted enzymatic reactions or proteins can be immunoprecipitated (IPed) following 
metabolic incorporation and reacted while held on the solid phase. Such analyses have been per-
formed for multiple fatty acylated proteins including Ras, LAT, Fyn, PAK2, Lck and others from 
cells93,94,96,118-120,123 or animals118, as well as for prenylation: isolated proteins have been exam-
ined for farnesylation (Ras and Hdj-2101), geranylation100,166 and geranylgeranylation (progerin in 
the study on Hutchinson-Gilford progeria syndrome168). Immunoprecipitation and in-gel fluores-
cence combined with mutational analysis is helpful to establish the exact residues of modifica-
tion. In the case of IFITM3, a HA-tagged overexpression was studied to establish the role of 
palmitoylation in membrane clustering necessary for activity123. As an alternative to antibodies, a 
His tag can also be employed, as was done to verify a tagged, overexpressed bacterial lipopro-
tein169. Visualization has been achieved by the Staudinger reaction93,94,96-98,100,101 or Cu-
AAC94,97,98,118-120,123,166,168,169. SPAAC has also been employed to visualize a specific engineered 
protein in the unisolated environment of a cell surface133. Validation of protein lipidation status 
may alternatively be achieved by transient overexpression, reaction and examination of signal, as 
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was done by in-gel fluorescence for the validation of many candidate palmitoylated proteins 
identified by mass spectrometry122 or on blot in the overexpression of EGFP-Ras fusions in 
COS-7 cells118. Finally, an expected site of lipidation can be fused to proteins such as GFP for 
subsequent IP, reaction and detection, or for live fluorescence microscopy. This technique was 
taken to validate 15 proteins predicted to undergo post translational myristoylation during apop-
tosis96 and benefits from the use of general IP reagents as well as the ability to examine in vivo 
membrane localization. Visualization of fatty-acylation on isolated proteins has allowed radioac-
tivity-free study of the turnover of palmitoylation120. 
Visualization of lipid PTMs in proteomes 
Visualization of lipid PTMs during cell state and comparison of preferences have been globally 
surveyed. Fatty-acylation machinery preference for various fatty acid chain lengths from myristic 
to stearic acids has been surveyed on blot with the Staudinger reaction in RAW93 and Jurkat 
cells94. The profile of palmitoylated mitochondrial proteins has also been profiled on blot after ex 
vivo az-14-CoA incorporation95. Alkyne analogs from myristic to stearic acids (alk-12, alk-1 and 
alk-16) were directly compared to their azido counterparts (az-12 and az-15) using CuAAC with 
in-gel fluorescence94. Many cell lines were profiled, each showing uniqueness as well as com-
monalities suggesting both common pathways and distinctive regulation of fatty-acylation94. 
Both on-blot and in-gel, it was shown that the signal of NMT labeled proteins, which are prefer-
entially labeled with shorter length fatty acid chains, remains after treatment with hydroxyla-
mine, which cleaves the thioester bonds of proteins palmitoylated with longer fatty acids93,94,121. 
A later study extended the range of short chain fatty acids downward to include alk-8, alk-9, and 
alk-11121. In PC3 cells and it was discovered that signal from shorter chain lengths are hydroxyl-
32 
 
amine sensitivity121, consistent with proteins such as acyl carrier proteins that are covalently at-
tached to shorter length fatty acids attached via thioester bonds170. Bacterial chain length prefer-
ence was also surveyed, showing that the palmitic acid analog alk-14 was best incorporated onto 
proteins in E. coli169. Using the Staudinger reaction, post-translational myristoylation in Jurkat 
cells has been examined during apoptosis96,118, leading to validation of proteins with newly ex-
posed NMT sites96. Jurkat cell geranylgeranylation has been profiled with CuAAC, one and two-
dimensional electrophoresis and in-gel fluorescence102 as well as in mouse embryo fibroblasts168, 
and farnesylation was visualized by the Staudinger reaction and blotting in COS-1 cells101. 
 
To image the localization of fatty acylated proteins in cells, two studies have employed CuAAC 
in histochemical examination in HeLa cells94, PC3, RAW264.7 and mouse fibroblast L-cells121 
using clickable analogs from myristic to stearic acid. Methanol or triton X-100 have been em-
ployed to remove membrane lipids, leaving behind fixed proteins which were then visualized. 
While no particular colocalization with any subcellular marker was observed94,121, both studies 
found that fatty-acylated proteins are distributed in vesicle and membrane like structures, con-
sistent with membrane targeting of this class of PTM. Interestingly, in PC3 cells, the cleavage 
furrow formed during cytokinesis is rich in palmitoylated proteins121, indicating a function for 
fatty-acylation in the segregation events of membranes and other cellular materials during cell 
division. Also notably, during interphase, distinctive colocalization of tubulin and palmitoylation 




Identification of lipid-modified proteins 
The ability of bioorthogonal chemistry to attach an affinity handle after incorporation offers an 
obvious advantage to more traditional biochemical isolations such as analog-biotin fusions. 
Bioorthogonal techniques have been used to study fatty-acylation122, farnesylation101 and modifi-
cation by 4-hydroxynonenal (HNE)106,172 (a reactive unsaturated α,β aldehyde generated during 
reactive oxygen species (ROS) damage by peroxidation of polyunsaturated fatty acids (PUFA) 
which attacks cellular nucleophiles). In such analyses, metabolically lipidated proteins are la-
beled with a biotin secondary reagent and captured on streptavidin. Due to the very high affinity 
of the streptavidin biotin interaction, proteins can be identified by on-bead digestion with tryp-
sin101,106,122 and subsequent mass spectrometric identification. An alternative has been developed 
in the form of a photocleavable linker, but this requires the use of glass beads and induced no-
ticeable UV degradation of UV-eluted proteins172. 
 
In fatty acid analysis, alk-16 (ODYA-17) and CuAAC were applied to identify palmitoylated 
proteins from Jurkat cell membranes by on-bead digestion and MudPIT proteomics173. 125 pro-
teins were identified with high confidence including known GTPases, G-protein-subunits and re-
ceptors173. Of the many new candidate fatty-acylated proteins, a previously unknown family of 
uncharacterized serine hydrolases termed FAM108 was discovered; for this family, pal-
mitoylation determines plasma membrane localization173. Although alk-16, a stearic acid analog, 
was used, many N-myristoylated proteins were also selectively retrieved173, consistent with met-
abolic processing and fatty-acylation heterogeneity. Azido-farnesyl fed to COS-1 cells and sub-
sequent application of the Staudinger reaction resulted in the identification of 18 putatively far-
nesylated proteins101. Likewise, alkyne106,172 and azide106 HNE identified multiple proteins tar-
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geted by HNE. These included proteins involved in stress response106 like heat shock proteins 
(HSP), as well as plasma proteins such as human serum albumin (HAS) and apolipoproteins172. 
Sites of modification were identified in the latter case showing modification to take place mostly 
on histidine, followed by lysine and then cysteine172. 
 
Lipid modified proteins can also be identified using bioorthogonal chemistry without the use of 
affinity handles. In this case, detection tags such as fluorophores are installed and proteins are 
separated using traditional chromatographic or electrophoretic102 techniques. The isolated pro-
teins are then identified by mass spectrometry. This was applied to identify 10 geranylgeranylat-
ed proteins of the Rab and Ras families from MCF-7 cells102 and 21 putatively palmitoylated 
proteins from mitochondria95. 
Other applications 
Bioorthogonal lipid analogs have found use in a variety of other contexts. To enable latter chem-
ical modification, bioorthogonal chemistry can be combined with enzyme-mediated protein tag-
ging to install a derivatizable lipid in vivo or in vitro. This has been achieved by geranylation100, 
farnesylation167 and in E. coli simultaneously overexpressing Candida albicans NMT a recombi-
nant protein with an N-terminal NMT recognition sequence97,98, offering a strategy suited to 
large scale production. Likewise, surface proteins engineered to be substrates for azido caprylic 
acid (Az-8) transferred by a microbial lipoic acid ligase can be easily visualized by SPAAC 
fluorophores133. Derivatizable liposomes allow modular installation of multiple targeting rea-
gents, such as antibodies or peptide ligands, and imaging agents. Liposomes with terminal acety-
lenic lipids have been applied to imaging the uptake by UMR-106 cells when derivatized with a 
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FITC dye and an integrin receptor uptake peptide GRGD174. Likewise, azide phospholipids al-
lowed derivatization with an N-terminally labeled fluorescent peptide, GPGGCGG, which was 
taken up by HeLa cells175. Finally, lipid modification of DNA constructs accelerated the uptake 
of oligonucleotides and did not inhibit biological activity176. 
 
Scope of this work 
Building on this foundation, this work set out with two goals. First at the level of proteins, to de-
velop a robust platform for affinity enrichment and identification of chemical reporter modified 
proteins. This system must have low background, must keep all proteins in solution, and must al-
low quantitative release of captured proteins. Second, this work sought to apply bioorthogonal 





MATERIALS AND METHODS 
 
Proteomic analysis 
HPLC-MS analysis of biotinylated detection tags 
Biotinylated detection tags were diluted to 100 µM in 50 mM triethanolamine (TEA), 150 mM 
NaCl and treated for 1 hr with the different reductants listed in Figure 8. The reactions were ter-
minated by reverse phase extraction on a C18 column, washed, eluted and vacuum concentrated. 
Samples were analyzed on a Waters Acquity HPLC and separated on a C18 column. The gradi-
ent of solvent A (water with 0.1% TFA) and solvent B (CH3CN with 0.1% TFA) was increased 
from 1% B to 40% B over 9 min, 60% B for 1 min and 100% B for 2 min. Mass to charge ratios 
were determined on a Thermo Scientific TSQ Vantage triple stage quadrupole. 
Cell culture and metabolic labeling 
Jurkat T cells (human T lymphoma) were cultured in RPMI medium 1640 supplemented with 
10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 mg/mL streptomycin (P/S). Cells 
were maintained in a humidified 37 °C incubator with 5% CO2. Trypan blue exclusion was used 
to determine cell viability. Cells were labeled at 5 x 106 cells/mL for 8 hours in 25 µM myristic 
acid analogs (alk-12 and az-12) or 50 µM palmitic (alk-14) and stearic acid analogs (az-15 and 
alk-16) in RPMI 1640 containing 2% charcoal dextran-treated FBS (CD-FBS) and P/S. Cells 
were spun down, washed once with PBS, snap frozen in liquid N2 and stored at -80 °C. 
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Preparation of total cell lysates 
Cells were lysed first in a hypotonic buffer (5 mM TEA, pH 7.4, 5 mM MgCl2, 10 mM PMSF, 
Roche Complete EDTA-free protease inhibitors) to which benzonase at 1000 U/mL had been 
added. Cells were intermittently vortexed and sonicated for 30 min at 4 ºC after which an equal 
volume of 8% SDS, 300 mM NaCl, 100 mM TEA pH 7.4 was added. Cells were again sonicated 
and incubated for 10 min at RT room temperature (RT); at this point the solution was clear. The 
supernatant was centrifuged at 10,000 g, 0 ºC for 30 min and the supernatant removed and stored 
at -80 ºC until future use. Protein concentration of cell lysates was determined by a BCA assay 
using BSA as a standard and equal amounts of protein from 2-20 mg were precipitated overnight 
with 8 volumes of methanol at -80 ºC. The precipitated proteins were resolubilized to 5-15 
mg/mL in 4% SDS, 150 mM NaCl and 50 mM TEA pH 7.4 containing 0.5 mM PMSF and 1x 
Roche Complete protease inhibitors with sonication. 
CuAAC labeling of cell lysates and in-gel fluorescence scanning 
Cell lysates were labeled in 4% SDS, 150 mM NaCl and 50 mM TEA with protease inhibitors at 
1 mg/mL. Protein was reacted for 2 hr at RT with 100 µM azido- or alkynyl-Rho or biotinylated 
detection tags from a 10 mM DMSO stock solution, 1 mM tris(2-carboxyethyl)phosphine hydro-
chloride (TCEP) from a 50 mM freshly prepared aqueous stock solution, 100 µM tris[(1-benzyl-
1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) from a 25 mM DMSO stock and 1 mM CuSO4 from 
a 50 mM freshly prepared aqueous stock solution. The reactions were terminated by the addition 
of 8 volumes of -20 °C methanol and placed at -20 °C overnight. Precipitated proteins were pel-
leted by centrifugation (18,000 g, 10 min, at 0 °C) and the supernatant discarded. Protein pellets 
were air dried for 10 min, resuspended in 35 µL of resuspension buffer (4% SDS, 50 mM trieth-
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anolamine pH 7.4, 150 mM NaCl), diluted with 12.5 µL 4X reducing SDS-loading buffer (40% 
glycerol, 200 mM Tris-HCl pH 6.8, 8% SDS, 0.4% bromophenol blue) and 2.5 µL 2-
mercaptoethanol, heated for 5 min at 95 ºC and ~20 µg of protein was loaded per gel lane for 
separation by SDS-PAGE (10% or 4-20% Bio-Rad Criterion Tris-HCl gel). Protein gels were 
then visualized by in-gel fluorescence scanning with an Amersham Biosciences Typhoon 9400 
variable mode imager (excitation 532 nm, 580 nm filter, 30 nm band-pass). 
Immunoprecipitations and CuAAC labeling/in-gel fluorescence scanning 
Jurkat cells were labeled and lysed as described above with the exception that 8% SDS was re-
placed with 2% Brij-97 for a final lysate in 1% Brij-97, 50 mM TEA pH 7.4 and 150 mM NaCl. 
500 µg of Brij cell lysate was mixed with 10 µL protein G beads and 2 µg anti-HSP90 and incu-
bated for 1 hr with agitation at RT. Beads were washed 3x with Brij-97 buffer and resuspended 
in 14 µL of 4% SDS buffer containing all CuAAC reagents. Histone IPs were performed as de-
scribed before177. Beads were reacted for 1 hr at RT after which 5 µL of 4X LDS sample buffer, 
1 µL BME was added and 20 µL of supernatant taken and analyzed by SDS-PAGE. Gels were 
scanned as described above.  
Transfection and metabolic labeling of constructs bearing exogenous tags 
293T cells were grown to 95% confluency in DMEM supplemented with 10% and 100 U/mL 
penicillin and 100 mg/mL streptomycin. Cells were transfected with various plasmids using 
lipofectamine-2000 according to the manufacturer’s instructions. After 10 hr, media was sup-
plemented either with 100 µM palmitic acid or 100 µM alk-14. 8 hr later cells were harvested us-
ing a cell scraper, washed with PBS and frozen at -80 ºC until use. Protein pellets were handled 
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identically as for Jurkat cells. Plasmids were as follows: PP1γ C-terminally tagged with EGFP 
pEGFP-C1 (Lei Tan and Tarun Kapoor), HSP90α N-terminally His- and C-terminally 3×FLAG 
tagged in pcDNA3.1+ (Laura Donlin and Alexander Tarakhovsky) and H3 variants C-terminally 
Myc-His tagged in pcDNA4 (Aaron Goldberg and David Allis178). 
Western blot analysis 
Proteins separated by SDS-PAGE were transferred (50 mM Tris, 40 mM glycine, 0.0375% SDS, 
20% MeOH in deionized water, Bio-Rad Trans-Blot Semi-Dry Cell, 20 V, 1 hr) onto a PVDF 
membrane. PVDF membrane was incubated with PBST (0.1% Tween-20 in PBS) or PBST with 
25 mM Na2S2O4 for 1 hr, and then with PBST containing blocking buffer (5% non-fat dried 
milk, 1% BSA and 0.1% Tween-20 in PBS) for 1 hr at 25 °C. The membrane was washed thrice 
with PBST, incubated with primary antibodies (manufacture’s recommendations) and horserad-
ish peroxidase-conjugated secondary-antibodies (~1:20,000 in PBST, Jackson ImmunoResearch, 
West Grove, PA) and subsequently developed with ECL Western blotting detection reagents 
(Amersham). 
Streptavidin enrichment of azide/alkyne-modified proteins 
Total cell lysates were reacted with azido- or alkynyl-biotinylated detection tags as described 
above and protein pellets washed with -80 °C methanol thrice. The protein pellet was resuspend-
ed in 4% SDS buffer to which 10 mM EDTA was added to solubilized protein-chelated copper. 
The labeled cell lysate was diluted to ~0.5% SDS with 1% Brij 97 in 150 mM NaCl, 50 mM 
TEA at pH 7.4 and incubated with streptavidin agarose (0.2 mL slurry/1 mg of protein) for 1 hr 
at RT. The streptavidin beads were washed in batch format with 6 times with of 20 column vol-
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umes of 2% SDS in PBS, 8 M urea in 250 mM ammonium bicarbonate (ABC), 2.5 M NaCl in 
PBS, 0.5 M ABC, 0.25 M ABC and finally 0.05 M ABC. Proteins were eluted from the streptav-
idin beads with 150 µL of 25 mM sodium dithionite in 0.25% SDS twice and subsequently with 
150 µL 25 mM sodium dithionite in 8 M urea twice for 15 min each at RT. The sodium dithio-
nite eluent were combined, exchanged to 50 mM ABC and concentrated to 14 µL on a 10 kDa 
MW Centricon. The recovered protein were then diluted with reducing SDS-loading buffer, 
heated for 5 min at 95 ºC, separated by SDS-PAGE on 4-20% Tris-glycine gels and stained with 
Coomassie blue. Each lane from the gel were cut into 10-24 pieces and digested by previously 
described protocols 179. Samples were analyzed on an LTQ-Orbitrap and data analyzed as de-
scribed below. A total of 18 runs were analyzed, composed of 6 negative controls (DMSO), 5 
myristic acid analog (az-12/alk-12), 3 palmitic acid analog (alk-14) and 4 stearic acid analog (az-
15/alk-16). 
Liquid chromatography – mass spectrometry (LC-MS) analysis 
LC-MS analysis was performed with a Dionex 3000 nano-HPLC coupled to an LTQ-Orbitrap 
ion trap mass spectrometer (Thermo Fisher). Peptides were pressure loaded onto a homemade 75 
μm diameter, 15 cm C18 reverse phase column and separated with a gradient running from 95% 
buffer A (HPLC water with 0.1% formic acid) and 5% buffer B (HPLC grade CH3CN with 0.1% 
formic acid) to 55% B over 30 min, next ramping to 95% B over 10 min and holding 95% B for 
10 min. One full MS scan (300-2000 MW) was followed by 3 data-dependent scans of the nth 
most intense ions with dynamic exclusion enabled. The spray voltage was set to 1.94 kV and the 
flow rate through the column was set to 0.25 μL/min. 
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Analysis of protein hits from mass spectrometry data 
Peptides were identified using SEQUEST version 28 (revision 13) and X!Tandem searched 
against the human IPI database version 3.50 (74,016 entries); searches were also run against the 
same database containing a randomized version of all sequences (148,032 entries). Mass toler-
ances were set at 10 ppm precursor mass and 1 Da fragment mass. Cysteines were considered 
constantly modified by carboxyamidomethylation. Allowable variable modifications in SE-
QUEST included oxidation on methionine and tryptophan, deamidation of asparagine and gluta-
mine, and acetylation on the N-terminus and lysine; lysine acetylation was rarely observed ex-
cept for histones. Allowable variable modifications in X!Tandem were the same with the addi-
tion of amino acid cyclization with an N-terminal glutamine or iodoacetamide-capped cysteine (-
NH3), or glutamic acid (-OH) resulting in N-terminal pyrrolidone carboxylic acids.  
 
SEQUEST and X!Tandem search results were imported into Scaffold for PeptideProphet filter-
ing. To generate a large space for PeptideProphet to model possible incorrect identifications, 
peptides were initially searched against a database generated with KRNLH trypsin specificity al-
lowing 5 missed cleavages. Only peptides judged by PeptideProphet to have a ≥95% likelihood 
of correct assignment were accepted. PeptideProphet probabilities are a combined function of 
both Xcorr and ∆cn and, in particular with high mass accuracy data, some spurious peptide iden-
tifications received a high probability due to a very high ∆cn despite a low Xcorr (i.e. < 1). These 
spurious hits represent, for example, environmental contaminants which match very well in mass 
to one possible peptide, but which exhibit minimal fragmentation. Thus, in addition to the prima-
ry PeptideProphet probability filter, all peptide identifications with an Xcorr ≤1, ∆cn ≤ 0.02 or E 
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≤ 1 were deemed unacceptable. With these filter criteria, SEQUEST Xcorr averaged ~3.1 and 
X!Tandem E ~2.9.  
 
After this peptide-level filter, proteins were deemed identified if they matched two or more tryp-
tic peptides with a maximum of three missed cleavages. After this, high probability semi- and 
non-tryptic peptides from the initial broad search were accepted as additional sequence coverage. 
Only proteins identified in more than two runs are listed. This analysis was also performed with 
a randomized database appended to the real sequences. No randomized proteins were present af-
ter these filter criteria. Proteins were allowed to share homologous peptides and redundant pro-
teins were identified similar to the procedure described by Kearney et al. 180. Protein accession 
numbers matching a subset of peptides were determined and are indicated but not counted in the 
number of identified proteins. For example, if protein P1 is matched by peptides A, B and C and 
protein P2 is matched by A and B, P2 is listed as a subhit and not counted. Likewise, in the case 
that two accession numbers match exactly the same peptides, the first (lowest numerical) IPI ac-
cession number is reported and the others are listed and not counted. Note that all accession 
numbers matching a distinct set of peptides are listed. For example, if protein P3 is matched by 
peptides D, E and F; protein P4 is matched by peptides D, E and G, and protein P5 is matched by 
peptides D, F and G, then P3, P4 and P5 will all be listed. In these cases, accession numbers are 
highlighted with an asterisk. Appendix Table 7 lists the peptides associated with each IPI acces-
sion number with shared peptides underlined and Appendix Table 8 lists all IPI numbers which 




Independent MS runs were normalized by determining the analog with the most accepted and 
identified peptides (“counts”) in each run and normalizing those maximum counts to a constant 
value. This normalization constant was then applied to the counts for all proteins of all other ana-
logs; averaged normalized counts were calculated for each protein across all runs. The first two 
myristic acid analog experiments were handled slightly differently because these experiments 
lacked other analogs. In this case, the average of the normalized myristic acid signal from all ex-
periments except the first two was first calculated and a constant was calculated to bring the total 
maximum signal of myristic analog counts to this normalized average. To allow presentation 
across different abundances, these averaged, normalized spectral counts were presented as per-
centage of maximum, with full red representing 100% of maximal signal strength and full white 
representing 0%. Figure 10 also shows the total positive abundance and total abundance normal-
ized for protein molecular weight. For the normalized abundance, spectral counts were scaled 
such that: 1) the total number of counts remains the same; and 2) counts are linearly scaled by 
the molecular weight of the proteins. Thus, if two proteins, P1 at 50 kDa and P2 at 100 kDa, 
were both observed to have 10 spectral counts, the adjusted abundance of P1 would be 13.3 and 
P2 would be 6.7 (total = 20 and P1 abundance twice that of P2). 
Bioinformatic analysis of protein identifications 
For prediction of N-myristoylation and S-palmitoylation, MYRbase and CSS-Palm were used re-
spectively. In the case of N-myristoylation, three levels of confidence in order of decreasing cer-
tainty were respectively given the numerical value (red shading) of 100%, 67% and 33%. Confi-
dence levels of 100% and 67% correspond respectively to the “RELIABLE” and “TWILIGHT 
ZONE” predictions of MYRbase. The lowest confidence level reflects no prediction of myristoy-
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lation by MYRbase, but the presence of an N-terminal glycine or methionine-glycine. Likewise, 
protein sequences predicted to be palmitoylated by the CSS-Palm set at the “high,” “medium,” 
and “low” cutoffs were assigned S-palmitoylation prediction confidence values of 100%, 67% 
and 33% respectively. For comparison of our data with published data sets, three separate ap-
proaches were required for each published set. For comparative analysis of Martin and Cravatt 
data, both IPI numbers and gene symbols were compared. High confidence proteins were as-
signed 100% confidence and medium confidence proteins 50% coloration. In all comparisons, 
caution must be exercised as each IPI number may have more than one gene symbol and likewise 
one gene symbol may exist for multiple IPI numbers. Due to the difference in species, all com-
parisons involving the Davis data were performed solely at the level of gene symbol (protein 
homology). Gene symbols for all accession numbers from both datasets were taken from current 
database entries; in the cases where gene symbols had not yet been entered, they were deter-
mined by BLAST. Gene symbols were compared and the confidence for Davis data calculated as 
follows: for both the cultured neuron and rat synaptosomal fractions, confidences of 50%, 33% 
and 16.7% were assigned to high, medium and low confidence protein identifications as classi-
fied by Davis and coworkers. The confidences for the cultured neuron and rat synaptosomal frac-
tions were then summed, so that a protein found in both and characterized at a high confidence 
received a total of 100% confidence, while a protein found once in a high confidence and once in 
a medium confidence would receive 83% red shading. For Zacharias data, all reported peptides 
were searched against the human IPI database; these IPI numbers were compared to the data 
here. Those peptides observed more than once were assigned 100% confidence, while those ob-
served once were assigned 50% confidence. Freeman data was treated like Cravatt with high 
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confidence proteins assigned 100% coloration and medium confidence identifications assigned 
50%. 
Cholesterol imaging 
Az-chol181, az-1594, TBTA and alkyne-rhodamine94 were prepared as previously described. M-12 
cells were kindly provided by Dr. Daniel Ory (Washington University in St. Louis, Saint Louis, 
MO). 293T-Shh cells were obtained from American Type Culture Collection (cat. no. CRL-
2782, Manassas, VA). Cell-culture grade cholesterol (C3045) and palmitic acid (P5585), filipin 
(F4767), cyanogen bromide activated Sepharose 4B fast flow beads (C9142), FITC-conjugated 
cholera toxin B (C1655) muristerone A (M7888), paraformaldehyde (158127), glutaraldehyde 
(G5882), cell culture grade DMSO (D2438), ultrapure benzonase (E8263) and methyl-β-
cyclodextran (C4555) and all buffer reagents were purchased from Sigma (St. Louis, MO). 
SYTO 11 (S7573), DAPI (D3571), Zeocin (R250), ProLong Gold and Gibco cell culture media 
were purchased from Invitrogen (Carlsbad, CA). Sera were obtained from Omega Scientific 
(Tarzana, CA). 20% and 4 – 20% Tris-HCl Criterion gels were from Biorad (Hercules, CA). An-
tibodies against calreticulin (1:500, ab2907, Abcam, Cambridge, MA), LAMP-1 (1:500, 
ab24170, Abcam), EEA1 (1:100, 2411, Cell Signaling Technology, Danvers, MA), and golgin-
97 (1:100, ab33701, Abcam) were used. Anti-N-Shh clone 5E1182 was obtained from the Devel-
opmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA). Polyclonal goat anti-
mouse Shh (AF464) was purchased from R&D Systems (Minneapolis, MN). HRP conjugated 
anti-goat secondary (705-035-147) was obtained from Jackson ImmunoResearch Laboratories 
(West Grove, PA). 
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Cell culture, metabolic labeling and Shh induction 
293T and 293T-Shh cells were cultured in high glucose DMEM with glutamine containing 10% 
fetal bovine serum (FBS), 100 U/mL penicillin and 100 µg/mL streptomycin. Both cell lines 
were grown to 30 to 40% confluency at which time medium was changed, replacing FBS with 
10% delipidated charcoal-dextran filtered fetal bovine serum (CDFBS). 293T-Shh cells were se-
lected by the inclusion of Zeocin (360 µg/ml), and G418 (400 µg/ml). CHO and M12 cells were 
cultured in F-12 with 10% delipidated CDFBS, 100 U/mL penicillin and 100 µg/mL streptomy-
cin. Cells were maintained in a humidified 37 ºC incubator with 5% CO2. For microscopy, cells 
were cultured on glass coverslips in 24-well tissue culture plates. 
 
Stock solutions of 50 mM cholesterol and az-chol were prepared in absolute ethanol. 50 mM 
stocks of palmitic acid and az-15 were kept in cell culture grade DMSO. All stocks were stored 
at –20 C. For all experiments, lipids were added into warm culture media containing 10% 
CDFBS and placed in a sonication bath for 30 min – 1 hr. The temperature of the culture media 
and bath water was continually monitored; sonication was paused above 40 ºC to allow for cool-
ing. Metabolic labeling of CHO and M12 cells for visualization was done at 50 µM cholesterol 
or az-chol for ~16 hrs (overnight). 293T and 293T-Shh cells labeled identically except at 100 
µM; palmitic acid or az-15 was applied at 12.5 µM for 8 hr. 293T-Shh cells were grown to ~90% 
confluency and induced with 1 µM muristerone A from a 10 mM stock in absolute ethanol for 8 
hrs prior to addition of medium containing cholesterol or az-chol; Zeocin and G418 were elimi-
nated from induction media. 8 hrs later, palmitic acid or az-15 was added. 293T and 293T-Shh 
cells were harvested 8 hr later after three PBS washes and prepared as described below. 
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Cell lysate preparation, CuAAC labeling and in-gel fluorescence imaging 
For analysis by SDS-PAGE, 293T and 293T-Shh cells were lysed in hypotonic buffer (5 mM 
TEA, pH 7.4, 5 mM MgCl2, 10 mM PMSF, Roche Complete EDTA-free protease inhibitors at 
20x) to which benzonase at 1000 U/mL had been added. Cells were intermittently vortexed and 
sonicated for 30 min at 4 ºC after which an equal volume of 8% SDS, 300 mM NaCl, 100 mM 
TEA pH 7.4 was added. Cells were again sonicated and incubated for 10 min at RT; at this point 
the solution was clear. The supernatant was centrifuged at 10,000 g, 0 ºC for 30 min and the su-
pernatant removed and stored at -80 ºC until future use. Cell lysis for immunoprecipitation was 
identical with the exception that 8% SDS was replaced with 2% Brij-97 for a final lysate in 1% 
Brij-97, ~50 mM TEA and ~150 mM NaCl; a pellet was present with Brij lysis. Protein concen-
tration of cell lysates was determined by a BCA assay using 2 mg/mL BSA as a standard. 
 
Cell lysates were labeled in 4% SDS, 150 mM NaCl and 50 mM TEA with protease inhibitors at 
1 mg/mL. Protein was reacted for 2 hr at RT with 100 μM alk-Rho from a 10 mM DMSO stock 
solution, 1 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP) from a 50 mM freshly pre-
pared aqueous stock solution, 100 μM tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine 
(TBTA) from a 25 mM DMSO stock and 1 mM CuSO4 from a 50 mM freshly prepared aqueous 
stock solution. The reactions were terminated by the addition of 8 volumes of -20 °C methanol 
and placed at -20 °C overnight. Precipitated proteins were pelleted the next day by centrifugation 
(18,000 g, 10 min, at 0 °C and the supernatant discarded. Protein pellets were air dried for 10 
min, resuspended in 35 μL of resuspension buffer (4% SDS, 50 mM triethanolamine pH 7.4, 150 
mM NaCl), diluted with 12.5 μL 4X reducing SDS-loading buffer (40% glycerol, 200 mM Tris-
HCl pH 6.8, 8% SDS, 0.4% bromophenol blue) and 2.5 μL 2-mercaptoethanol, heated for 5 min 
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at 95 ºC and ~20 μg of protein was loaded per gel lane for separation by SDS-PAGE (10% or 4-
20% Bio-Rad Criterion Tris-HCl gel). Protein gels were then visualized by in-gel fluorescence 
scanning with an Amersham Biosciences Typhoon 9400 variable mode imager (excitation 532 
nm, 580 nm filter, 30 nm band-pass). 
Immunoprecipitation and Western blotting 
Ascites fluid containing anti-N-Shh monoclonal antibody 5E1 was buffer exchanged against wa-
ter with a Pierce Zeba column and coupled as per manufacturer’s instructions to CNBr-activated 
Sepharose 4B. 750 µg of induced 293T-Shh Brij lysate was mixed with 15 µL 5E1 beads and in-
cubated for 1 hr with agitation at RT. Beads were washed 3x with Brij-97 buffer and resuspend-
ed in 28 µL of 4% SDS buffer containing all CuAAC reagents. Beads were reacted for 1 hr at RT 
after which 10 µL of 4X LDS sample buffer and 2 µL 2-mercaptoethanol were added. The reac-
tion was sonicated, supernatant removed and analyzed by SDS-PAGE. 19 µL was applied to a 4 
– 20% tris-HCl gel for fluorescence scanning as described above; 19 µL was applied to a 20% 
tris-HCl gel for Western blotting. Blots were transferred (50 mM Tris, 40 mM glycine, 0.0375% 
SDS, 20% MeOH in deionized water, Bio-Rad Trans-Blot Semi-Dry Cell, 20 V, 40 min) onto a 
PVDF membrane and the membrane was blocked in 0.1% Tween-20 in PBS (PBST) with 5% 
non-fat dried milk and 1% BSA for 1 hr at 25 °C. After a short rinse, the blot was incubated with 
goat anti-N-Shh at 1:500 in 5% casein, 1% BSA in PBST, washed three times and incubated with 
horseradish peroxidase-conjugated secondary-antibodies (~1:15,000 in PBST). Blot was subse-
quently developed with ECL Western blotting detection reagents (Amersham). 
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Cellular az-chol labeling and filipin staining 
Cells grown on coverslips were washed three times with PBS prior to fixation. Cells to which 
only chemical techniques were applied were fixed in 1% glutaraldehyde and 4% PFA in PBS for 
1 hr; fixation for antibody staining was with 4% PFA for 15 min at RT. Both fixations were fol-
lowed by 3 x 5 min PBS washes. Cells were subsequently blocked for 1 hr in 20% CDFBS at RT 
followed by 3 x 5 min PBS washes. Samples intended for antibody analysis were permeabilized 
with 1% tween-20 in PBS for 10 min at RT. Alternatively, cholesterol was depleted by the addi-
tion of -20 ºC HPLC grade methanol (JT Baker) for 10 min or 10 mM MβCD in PBS for 10 min. 
In both cases, samples were again washed 3 x 5 min PBS. Primary antibodies were applied in 
PBST for 1 hr followed by 3 x 5 min PBST washes. Fluorescent conjugated secondary antibodies 
diluted 1:750 in PBST were applied for 45 min followed by the same washing. For all samples, 
filipin was prepared at 25 µg/mL in PBS; reagents for CuAAC were added to this solution at the 
same concentrations as with labeling of cell lysates and samples were labeled for 1 hr. Samples 
were then washed 3 x 5 min in PBST containing 5 mM EDTA, followed by 5 min incubation in 
1:40,000 SYTO 11 and 2 x 5 min PBS washes. Cells were mounted in Prolong Gold and imaged 
as described below. All negative controls were handled identically and in parallel with az-chol 
labeled samples. 
In vivo az-chol labeling and tissue sectioning 
Mice work was performed according to approved Memorial Sloan-Kettering animal protocols. 
Swiss-Webster mice pregnant with E12.5 embryos were anesthetized with isoflurane. In the su-
pine position, a 4 cm vertical incision was made from below the ribcage to middle of the intes-
tines. The uterine horns were carefully laid on a sterile field and 1 – 2 µL of 50 mM az-chol 
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stock mixed with 1 – 1.5 µL cell culture grade DMSO was injected directly into the lateral ven-
tricle of a single embryo using a pulled glass capillary needle. Upon completion, the uterus was 
returned to the abdominal cavity, the skin and muscle were sutured closed and the closure was 
reinforced with veterinary staples. The analgesic buprenorphine (Buprenex™) was administered 
at a dose of 0.1 mg/kg and the mouse was removed from the anesthetic and placed on a warming 
pad for recuperation. Once awoken, the mouse was returned to its cage for 6 hours for analog in-
corporation. After incorporation, the embryos were collected and decapitated. The heads were 
immediately fixed in 4% paraformaldehyde-PBS for 20 minutes, cryoprotected in 30% sucrose 
in PBS and embedded in OCT for cryo-sectioning. 14 µm sections were cut on a Leica3050 S 
cryostat; mounted sections were stored at -20 ºC until use. Tissues were mounted and fixed sec-
tions were hydrated with 3 x 5 min PBS, blocked as described above and washed again with 
PBST. CuAAC labeling was performed as described above with the exception that filipin was 
not included. After washing excess CuAAC reagents, samples were incubated with DAPI (5 
mg/mL solution diluted 1:40,000 in PBS) for 15 min followed by identical rinsing and mounting. 
All negative controls were handled identically and in parallel with az-chol labeled samples. 
Fluorescence microscopy 
All cell culture samples and high magnification brain images were obtained on a DeltaVision 
Applied Precision Image Restoration Inverted Olympus IX-70 microscope using a 60x oil objec-
tive. Images were deconvolved in SoftWoRx (Applied Precision / DeltaVision); identical image 
display settings were applied to positive and negative samples. Low magnification (10x) fluores-
cent images were collected on a Zeiss Axio Observer.Z1 microscope equipped with Axiovision 
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software. Pearson’s coefficients were determined in ImageJ with the JACoP (Just Another Colo-
calization Plugin) plugin (Fabrice P. Cordelieres, Institut Curie, Orsay, France).
52 
 
PROTEIN ACYLATION IN MAMMALIAN CELLS 
 
Introduction 
The diversity of fatty-acylated proteins and their mechanisms of regulations are not completely 
understood5. Prediction algorithms such as Myrbase183 and CSS-Palm22 provide useful bioinfor-
matic tools for the analysis of candidate fatty-acylated proteins based on previously observed 
modification motifs, but require experimental validation and offer no insight into the post-
transcriptional mechanisms of fatty-acylation. For example, alternative splicing of mRNA tran-
scripts may yield substrates for N-myristoylation as in the case of the p35 isoform of OCA-B, a 
transcription factor required for late-stage B cell development14,15. Alternatively, protein fatty-
acylation may be altered during cellular regulation. During programmed cell death, the apoptosis 
effector tBid is post-translationally N-myristoylated after proteolytic cleavage by the cysteine 
protease caspase-3, which targets tBid to mitochondrial membranes during apoptosis 12,13. Dis-
secting the regulatory mechanisms of S-palmitoylation in mammals also presents a significant 
challenge as ~23 DHHC-PATs have been identified in human and mouse genomes with overlap-
ping substrate specificities21. Moreover, the functions of fatty-acylated proteins can be regulated 
by other post-translational modifications (PTMs) such as phosphorylation, as exemplified by 
studies on MARCKS7, c-Abl kinase8,9 and potassium channels10. Robust experimental methods 













Figure 6  Protein fatty-acylation and its analysis with bioorthogonal chemical reporters. A) 
Chemical modification of fatty-acylated proteins. Palmitoylation is heterogeneous in length and 
saturation; only palmitic acid is shown. B) Schematic for proteomic analysis of fatty-acylated 
proteins with chemical reporters using cleavable affinity tags. Jurkat T cells were metabolically 
labeled with DMSO control (-) or alk-FAs (20 µM myristic analogs, 100 µM all other analogs; 
6-8 hr). Total cell lysates were then subjected to click chemistry reaction with az-azo-biotin (100 
µM), small molecule removal, affinity-enrichment with streptavidin-beads, selective elution 
from beads with sodium dithionite (Na2S2O4, 25 mM, 1 hr) and separation by SDS-PAGE. Selec-
tively recovered proteins were analyzed by immunoblot using specific antibodies or stained with 
Coomassie blue and processed for mass spectrometry-based protein identification. X = NH (N-
myristoylation) or S (S-palmitoylation). C) Profile of alkynyl-fatty acid-labeled proteins in total 
cell lysates visualized by click chemistry reaction with az-Rho/in-gel fluorescence scanning (left 
panel) or with az-azo-biotin, streptavidin enrichment, Na2S2O4 elution and Coomassie blue stain-
ing (right panel). Coomassie staining of total cell lysates from each sample (-, alk-12, alk-14, 
alk-16) demonstrates comparable amounts of protein loading for both fluorescence imaging and 
affinity enrichment of labeled proteins (middle panel). Similarities such as the ~20kDa band 








Two chemical methods have been developed to overcome the limitations of radiolabeled fatty 
acids for the detection and identification of fatty-acylated proteins184. The acyl-biotin exchange 
(ABE) protocol developed by Drisdel and Green exploits the differential sensitivity of thioesters 
to hydroxylamine (NH2OH) for selective biotinylation of S-acylated proteins and non-radioactive 
visualization by streptavidin blot185 as well as enrichment of S-acylated peptides or proteins for 
proteomic analysis by mass spectrometry186-189. The global profiling of S-palmitoylation in bud-
ding yeast with ABE identified several new S-palmitoylated proteins and highlighted the differ-
ential and overlapping substrate specificities of the DHHC-PATs186,187. The application of ABE 
to neurons revealed isoform-specific S-palmitoylation of the GTPase Cdc42 in the brain as well 
as many new candidate S-palmitoylated proteins188. Enrichment of S-acylated peptides from 
mammalian cells by ABE has also expanded the list of S-palmitoylated proteins and sites of S-
acylation189,190. Alternatively, we93,99,191 and others95-98,121,122,192 have developed fatty acid chem-
ical reporters of protein fatty-acylation that enable rapid non-radioactive detection of fatty-
acylated proteins from mammalian cells using bioorthogonal ligation methods109 such as the 
Staudinger ligation or CuI-catalyzed [3+2] azide-alkyne cycloaddition (CuAAC)184,193 (Figure 6). 
Metabolic labeling of mammalian cells with azido/alkynyl-fatty acid (az/alk-FA) chemical re-
porters followed by reaction of azide/alkyne-modified proteins with biotinylated or fluorescent 
detection tags allows the visualization of fatty-acylated proteins by streptavidin blot93,95-99,121 or 
in-gel fluorescence122,191,192,194, respectively. The direct comparison of various detection modes 
has demonstrated that metabolic labeling of cells with alkynyl-fatty acids (alk-FAs) in combina-
tion with CuAAC and in-gel fluorescence scanning affords the optimal method for the visualiza-
tion of protein fatty-acylation191. Indeed, the analysis of various mammalian cell lines with fatty 
acid chemical reporters and CuAAC/in-gel fluorescence scanning revealed unique and diverse 
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profiles of fatty-acylated proteins191. Large-scale profiling of S-acylated proteins in Jurkat T cell 
membrane fractions with an alkynyl-palmitate reporter (17-octadecynoic acid abbreviated 17-
ODYA or alk-16) by Martin and Cravatt using CuAAC labeling/enrichment methods, on-bead 
proteolysis and multidimensional protein identification technology (MudPIT) recovered many 
new candidate S-palmitoylated proteins and identified a family of serine hydrolases that is tar-
geted to membranes by palmitoylation122. Herein, we describe the proteomic analysis of fatty-
acylated proteins in mammalian cells in which we employ a series of fatty acid chemical report-
ers representing myristic to stearic acids (Figure 6). This survey is unbiased in that all cellular 
proteins were solubilized and analyzed; no fractionation such as membrane preparations was 
used. Our studies of total cell lysates from Jurkat T cells have revealed known and novel candi-





Characterization of cleavable affinity reagents for CuAAC-based proteomics 
To facilitate the identification of azide- and alkyne-modified proteins targeted by bioorthogonal 
chemical reporters, we utilized clickable and cleavable affinity reagents for CuAAC, streptavidin 
enrichment and selective elution of recovered polypeptides for proteomic analysis (Figure 6). 
While the biotin-avidin interaction provides an excellent system for selective detection and re-
trieval of biomolecules, the high affinity binding (~KD 10-15 M) of this interaction makes quanti-
tative elution of biotinylated proteins from streptavidin beads challenging. Indeed, selective elu-
tion strategies using protease-135,195,196, pH-197-199, redox-200-202 or photo-cleavable203-205 linkers 
have been described to recover peptides or proteins following streptavidin enrichment. We em-
ployed the azobenzene linker as this functional group can be efficiently cleaved by mild reduc-
tion with sodium dithionite200-202 (Na2S2O4, see  
 
Figure 7) and stable to click chemistry conditions177,206. Exposure of azido-azo-biotin previously 
generated by our laboratory177 to various reducing agents demonstrated the azobenzene linkage 
was stable to reducing agents such as TCEP (tris(2-carboxyethyl)phosphine), but readily cleaved 
with 25 mM Na2S2O4 (Figure 8) These experiments demonstrated that the cleavable affinity tags, 
alk-azo-biotin and az-azo-biotin, are compatible with click chemistry (1 mM TCEP) and reduc-
tive alkylation (10 mM TCEP) reaction conditions used for proteomic studies. We have previ-
ously utilized az-azo-biotin for CuAAC-based proteomic analysis of acetylated proteins in 
mammalian cells177 and lipoproteins in bacteria207. For this study, alk-azo-biotin was also synthe-
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Figure 7 Mechanism of azo cleavage by sodium dithionite. The first step can proceed in either a 


























Figure 8 Analysis of azido-biotinylated cleavable linker (az-azo-biotin) under reductive condi-
tions. A) Structures of reduced cleavable linkers and their mass to charge ratios. B) Linker at 100
µM was exposed to the different reducing conditions of panel B in 50 mM TEA, 150 mM NaCl
at pH 7.4. After reduction for 1 hr, reactions were stopped by reverse-phase solid phase extrac-
tion, washed, concentrated and analyzed by HPLC. Only 25 mM Na2S2O4 was able to cleave the
azo-benzene bond. Note the reduction of the terminal azide to an amine (NH2-azo-biotin) cannot









Figure 9 A) Azido-fatty acids. B) Clickable rhodamine dyes. C) Synthesis of alk-azo-biotin: (a) 
NaNO2, 6M HCl, 4-aminobenzoic acid. (b) 6-heptynoic-NHS ester, Et3N, THF, 30% yield over 







Proteomic analysis of fatty-acylated proteins in mammalian cells 
To identify proteins targeted by fatty acid reporters, az-FA- and alk-FA-labeled Jurkat T cell 
lysates were reacted with the alk-azo-biotin and az-azo-biotin, respectively, incubated with 
streptavidin beads and extensively washed with denaturing buffers to remove non-specifically 
bound proteins (Figure 6B). Proteins that remained bound to streptavidin beads were selective 
eluted with 25 mM Na2S2O4, separated by SDS-PAGE and analyzed by Coomassie blue staining 
or immunoblotted for specific proteins (Figure 6B). Coomassie blue staining of the polypeptides 
selectively eluted from streptavidin beads revealed significantly greater amounts of proteins 
recovered from alk-FA and az-FA-labeled cell lysates compared to control (-) (Figure 6C, Figure 
10B, D and E). A fraction of the cell lysates analyzed in parallel demonstrated equal levels of 
input material (Figure 6C). The profile of selectively recovered polypeptides roughly mirrors the 
fatty-acylated proteins visualized by CuAAC/in-gel fluorescence scanning although the modes of 
protein detection are different (Figure 6C). For example, the ~20 kDa polypeptide that is 
preferentially labeled in az-12/alk-12 cell lysates by in-gel fluorescence is also apparent by the 
Coomassie blue-stained gel of selectively recovered proteins from streptavidin enrichment and 
Na2S2O4 elution (Figure 6C, Figure 10C). Western blot analysis of az-FA-labeled samples for 
known fatty-acylated proteins in Jurkat T cells such as Lck93 and Tfr208,209 demonstrated the 











Figure 10 Enrichment of azide/alkyne-modified proteins targeted by fatty acid chemical report-
ers. A) In-gel fluorescence profile of azido-fatty acid labeled proteins from Jurkat T cells after 
CuAAC reaction with alk-Rho. B) Coomassie staining of azido-fatty acid labeled proteins fol-
lowing CuAAC reaction with alk-azo-biotin, streptavidin enrichment, sodium dithionite elution 
and SDS-PAGE. C) Validation of azido-fatty acid recovered proteins by western blot. D) Prelim-
inary runs of az-12 labeled proteins following CuAAC reaction with alk-azo-biotin, streptavidin 
enrichment, sodium dithionite elution and SDS-PAGE. E) Enrichment of alk-FA-modified pro-
teins after CuAAC labeling with az-azo-biotin, streptavidin enrichment, sodium dithionite elu-












Figure 11  Proteins identified from Jurkat T cells metabolically labeled with click-chemistry 
compatible fatty acids of different chain lengths (myristic acid = az- and alk-12), (palmitic = alk-
14), (stearic = az-15 and alk-16) or DMSO carrier control (-); high confidence only (≥ 5 identifi-
cations with 5-fold enrichment over DMSO control). Proteins with the same gene symbol but 
different IPI numbers are marked with an asterisks (*). Under experimental, intensity of heat 
map coloration represents normalized peptide counts for each protein hit averaged over 6 inde-
pendent proteomic experiments. Proteins are clustered by their propensity to be modified from 
short to long chain fatty acids and assigned to seven groups: I: modified mainly by myristic acid; 
II: modified mainly by myristic and palmitic acids; III: myristic and stearic acids; IV: palmitic 
acid; V: palmitic and stearic acids; VI: palmitic acid; VII: myristic, palmitic and stearic acids. 
Group VIII are proteins enriched in the negative control (marked with a dagger (†); counts are 
negatives in excess of positive). Proteins labeled by all fatty acids are sorted by the correlation 
between their averaged normalized signal strengths and the physical length of the fatty acid 
chains. Intensity of red in prediction and in comparative analysis to other reported experimental 
datasets represents confidence of prediction or identification, respectively, given criteria set by 
each study. N-terminal myristoylation was predicted by MYRbase. S-palmitoylated was predict-
ed by CSS-Palm. In comparative analysis, a black box means a protein was identifiable by our 
data which matched an accession number published in other data sets, but which differs from the 
reported accession number of this figure due to additional sequence coverage or uncertainty in 
peptide-level identification. A grey box represents the same situation, except that 1) both an un-
listed, interpretable accession number and the exact accession number listed match published re-
ports; and 2) the confidence of the unlisted number is higher than the accession number listed 
here. In that case, the higher confidence of the unlisted accession number is shown. The total 
number of peptide counts in excess of any negative (log scale) and the number of times the pro-

























Having confirmed the specificity and low background of CuAAC and affinity enrichment 
methods, we proceeded with the large-scale identification of proteins targeted by the az/alk-FAs 
in Jurkat T cells. Az/alk-FA-labeled and control total cell lysates were reacted with clickable and 
cleavable affinity reagents (alk-azo-biotin, az-azo-biotin, respectively), purified by streptavidin 
enrichment and sodium dithionite elution protocol described above (Figure 6B). The Coomassie 
blue-stained gels of the recovered proteins were then processed using standard protocols for gel-
based proteomics and analyzed by nano-reverse-phase liquid chromatography and tandem mass 
spectrometry for protein identification using the LTQ-Orbitrap. Two initial proteomic runs were 
performed with az-12-labeled cell lysates, followed by four additional experiments using az/alk-
FAs of different chain length (Figure 6C). Tandem MS/MS analysis of tryptic peptides followed 
by database searches using Sequest and X!Tandem with standard peptide hit filter criteria and 
two-unique peptide cut-off for protein identification revealed many known fatty-acylated 
proteins and new candidate fatty-acylated proteins not present in or significantly enriched 
compared to negative controls (Appendix Tables 1 and 2). Preliminary analysis of proteins 
selectively recovered from az-12 and alk-12-labeled cell lysates yielded a similar composition of 
protein hits (Appendix Tables 1, 2 and 6), which is consistent with our previous experiments that 
demonstrated az-FA and alk-FA both function as efficient chemical reporters of protein fatty-
acylation on known proteins such as Lck, LAT and Ras191. Proteomic data based on peptide 
spectral counts from negative control lanes (-, n = 6), myristic (az-12, n = 3 and alk-12, n = 3), 
palmitic (alk-14, n = 3) and stearic (az-15, n = 1, alk-16, n = 3) acid analogs were therefore 
combined and collated to evaluate proteins that were selectively labeled with fatty acid chemical 
reporters and separated into high and medium confidence groups (Appendix Tables 1 and 2). The 
normalized peptide spectral counts from the protein hits were represented in a heat map for 
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comparative analysis (Figure 11). A total of 178 proteins were identified > 5 times in az/alk-FA 
labeled cells with at least > 5-fold enrichment of normalized peptide counts compared to 
negative controls were sorted into the high confidence group; only two proteins were inversely 
enriched in the negative controls (Figure 11). Another 183 proteins in the medium confidence list 
were selectively identified at least twice in az/alk-FA labeled cells and yielded at least 3-fold 
enrichment of normalized peptide counts compared to negative control (Appendix Table 2). 
Direct comparison of selectively identified protein hits from two proteomic runs of alk-16 
performed in parallel suggested that the high confidence protein hits are reproducibly recovered 
from independent experiments. Many known candidate fatty-acylated proteins were recovered 
from our proteomic studies. For example, N-myristoylated proteins such as ADP-ribosylation 
factors (ARF1, ARF4 and ARF5), Src-family kinase Lck, protein phosphatase 1G (PPM1G), G-
protein subunits (Gi, Gk and Go) and myristoylated, alanine-rich protein kinase C substrate 
(MARCKS), as well as S-palmitoylated proteins including the transferrin receptor (TfR), 
calnexin (CANX), N-Ras, and tetraspanins (CD81 and CD82) were identified from az/alk-FA 





Figure 12 Immunoblot analysis of selectively recovered proteins. A) Known fatty-acylated pro-
teins. B) New candidate proteins. C) Robust enrichment of endogenously fatty-acylated HSP90. 
D) In-gel fluorescence detection of immunoprecipitated HSP90 metabolically labeled with al-
kynyl-fatty acid after CuAAC reaction with az-Rho. 
 
To evaluate the specific recovery of protein hits from az/alk-FA-labeled cell lysates in our 
proteomic dataset, total cell lysates and Na2S2O4 eluents were analyzed by Western blot. 
Immunoblot analysis for known fatty-acylated proteins such as transferrin receptor (TfR), Lck, 
calnexin (CANX), linker-associated with T cell activation (LAT), N-Ras, and ADF-ribosylation 
factors (ARFs) confirmed mass spectrometric identification and specific retrieval from az/alk-
FA-labeled cell lysates (Figure 12A). We also evaluated other proteins from our proteomic 
dataset that have not been previously confirmed to be fatty-acylated. For example, Western blot 
analysis for heat shock proteins (HSP90, GRP94), phosphatase subunits (PP1β, PP1γ) and other 
proteins (Ran, histone (H3), coronin-1A (COR1A), 14-3-3, transitional endoplasmic reticulum 
ATPase (p97/VCP) confirmed their selective retrieval and identification by mass spectrometry 
(Figure 12B). The analysis of fatty-acylated protein levels in total cell lysates compared to the 
amount of protein recovered from affinity enrichment affords a qualitative measure of how much 
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protein is metabolically labeled with fatty acid reporters. N-myristoylated proteins such as Lck 
and ARFs appeared to be recovered in significant amounts compared to total cell lysates (Figure 
12A). Interestingly, the S-palmitoylated protein LAT was robustly enriched in Na2S2O4 elutions 
compared to cell lysates (Figure 12A). In contrast, relatively low amounts of HSP90, GRP94, 
PP1β, PP1γ and Ran are recovered from fatty acid reporter labeling and affinity enrichment 
compared to cell lysates (Figure 12B), indicating a large dynamic range of fatty-acylation 
stoichiometry; the robust signal for known fatty-acylated proteins is likely a factor in their 
previous discovery. As expected, increasing the amount of alk-FA/CuAAC enriched proteins 
relative to total cell lysate demonstrated more robust relative signal intensity of alk-FA labeled 
endogenous HSP90 (Figure 12C). Fatty-acylation of endogenous HSP90 was also confirmed 
following alk-16 labeling of Jurkat cells, immunoprecipitation, CuAAC reaction with az-Rho 
and in-gel fluorescence scanning (Figure 12D). 
 
To further validate mass spectrometric and antibody detection of low level fatty-acylation of 
proteins and clarify highly homologous histone H3 variants, we analyzed the fatty acid reporter 
labeling and enrichment of overexpressed constructs bearing epitope-tags (Figure 13). These 
experiments employed alk-14, as this analog yielded the broadest labeling amongst the candidate 
proteins analyzed. The results for HSP90, PP1γ and the histone H3 variants recapitulated the data 
obtained for endogenously expressed proteins and revealed similar labeling and enrichment of 
histones H3.1, H3.2 and H3.3. Because all histone H3 variants share a single conserved cysteine 
at position 110, we analyzed alk-14 labeling and enrichment of epitope-tagged H3.2 and C110A 
mutant as well as endogenous calnexin in parallel as a positive control (Figure 13B). Although 
calnexin signal was similar for both alk-14 labeled samples, H3.2 labeling was completely 
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abrogated in C110A construct, indicating that Cys110 is the site of H3.2 fatty-acylation. These 
results highlight the utility of bioorthogonal chemical reporters for large-scale profiling of fatty-










Figure 13 Further validation of candidate proteins. A) Validation of Hsp90, PP1γ and histone H3
variants by transfection with tagged constructs. B) Identification of Cys110 in histone H3.2 as
the site of S-palmitoylation. While endogenous calnexin is similarly enriched and detected, all
recovery of H3.2 is lost with a C110A mutation. C) Isolation of histone H3 by immunoprecipita-




Figure 14 Overlap of fatty-acylated protein studies and analysis of selectively recovered proteins 
from this study. A) Comparative analysis of high and medium confidence protein hits recovered 
CuAAC studies by gene symbol and IPI numbers. For IPI numbers, parentheses represent values 
including possible interpretations of peptide identification not reported in Figure 2 or Supple-
mentary Figure 4. B) Overlap of this study with acyl-biotin exchange studies. C) Overlap of all 
CuAAC studies and ABE studies by gene symbol. D) Subcellular distribution of high confidence 
protein hits based upon WoLF PSORT prediction algorithm. E) Subcellular distribution of high 
confidence protein hits based upon biochemical fraction studies of Jurkat T cells. F) Biological 




Figure 15 A) Gene symbol overlap of all studies, high and medium confidence. B) Full overlap 
of high and medium confidences, all studies. C) Gene symbol overlap of high confidence only 
from all studies; in parentheses, high confidence of this study versus both high and medium con-
fidence of other studies. D) Frequency of gene symbol observation from all studies of fatty-
acylated proteins. E) Percentage of overlap between study pairs. Right axis: number of shared 
gene symbols. Left axis: percentage of overlap calculated as (the number of shared gene sym-




Comparative analysis of fatty-acylation proteomic studies  
A comparative analysis of our proteomics dataset with other recently described large-scale 
studies of fatty-acylated proteins122,188-190 yields a significant degree of overlap with reported 
fatty-acylated proteins as well as new candidate fatty-acylated proteins (Figure 14, Figure 15). 
The proteomic analysis of alk-16 (17-octadecynoic acid 17-ODYA) labeled Jurkat T cells by 
Martin and Cravatt using CuAAC ligation with biotin-azide, streptavidin enrichment and on-
bead digestion followed by multidimensional protein identification technology (MudPIT)-based 
protein identification yielded ~125 high confidence fatty-acylated protein hits and another ~200 
proteins with medium confidence122. Of the total list of fatty-acylated proteins identified by 
Martin and Cravatt, 52 IPI numbers (or 82 considering possible alternate identifications) and 94 
gene symbols were shared with our dataset, representing a 17% – 26% overlap (Figure 14A). 
Even the lowest possible interpretation, this overlap is statistically significant for any reasonable 
assumption of active genes. As determined by hypergeometric distribution,i the chance of 52 
proteins being randomly choosen for these survey sizes from the full 74,016 enteries of the IPI 
database is 1.08 E -67. At a reasonable number of expressible human genes, 24,500, the liklihood 
has grown to 1.74 E -43 and, assuming the 5381 proteins of Jurkat T cells identified by 
proteomics210 represent the full repitoir of expressed proteins, the chance increases to a still 
unlikely 1.60 E -13. The number of expressed proteins must fall below 2294 for the chances of 
                                                 
i The hypergeometric distribution calculates the chances of a given number of marked samples being taken from a 
finite population of marked and unmarked entities without replacement. In the classical example, if x marbles are 
taken from an urn with y white and z black marbles, it calculates the liklihood of choosing n black marbles. In this 
case, the urn would contain e.g. 74,016 marbles of which 361 (the number of proteins identified in this work) would 
be black. If 260 are chosen at random (the number of proteins identified in the Cravatt study), the chance of those 
260 containing 52 black marbles is 1.08 E -67. 
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random overlap to exceed 0.01, indicating that the overlap in protein identification is not 
random. 
 
In addition to the variability intrinsic to MS identification studies, two key features likely 
account for differences among our Jurkat T cell datasets. Our studies were performed with total 
cell lysates that included nuclear and cytosolic proteins, compared to enriched membrane 
fractions from the Martin and Cravatt studies122. Moreover, the clickable and cleavable reagents 
(alk-azo-biotin and az-azo-biotin) enabled the use of gel-based proteomics strategies, whereas 
Martin and Cravatt utilized on-bead protease digestion and MudPIT-based protein identification 
methods122. Our analysis also employed multiple fatty acid reporters, especially myristic acid 
analogs, and recovered N-myristoylated proteins (e.g. PPM1G, MARCKS, ARF4 and ARF5) not 
present in the Martin and Cravatt dataset (Figure 11), although alk-16 (17-ODYA) was also 
reported to target some N-myristoylated proteins122. While many known and new candidate 
fatty-acylated proteins from total cell lysates were identified in our high and medium confidence 
datasets (Figure 11), selective recovery and enrichment of some known S-palmitoylated proteins 
such as LAT not reaching those confidence levels could be clearly observed by Western blot 
analysis of sodium dithionite elutions (Figure 12). Time of incubation with fatty acid analogs, 
differential recovery of peptides by gel-based versus MudPIT proteomic strategies and subtle 
differences in MS analysis can all play a role for the differences in fatty-acylated protein 
profiling between this study and that of Martin and Cravatt. 
 
ABE yields complementary datasets in comparison to CuAAC-based systems, as metabolic 
incorporation of analogs is not required. The ABE analysis of membrane fractions from rat 
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neural sources by the Davis laboratory yielded ~113 high confidence and ~318 medium 
confidence S-acylated proteins211, 49 of these protein hits were also identified in our proteomic 
dataset when compared by gene symbol (Appendix Tables 1, 2 and 3). ABE can also be 
performed with isotopically-encoded thiol-alkylating reagents (iCAT) for comparative analysis 
of S-acylated peptides, which identified ~46 S-palmitoylated proteins as well as their potential 
sites of modification from HeLa cells189. Our study shares 29 gene symbols with this data and if 
peptides are searched against our dataset, 61 IPI numbers are common (Appendix Tables 1, 2 
and 3). These degrees of overlap are statistically significant (Table 5). ABE enrichment of S-
acylated peptides from lipid-raft and non-lipid raft associated proteins from a human prostate 
cancer cell line has also yielded ~67 known and ~331 candidate S-acylated proteins as well as 
many potential sites of Cys modification190; of these, 69 were also identified by our study by 
gene symbol or 68 by IPI number (Appendix Tables 1, 2 and 3). While the ABE and fatty acid 
reporter proteomic studies were performed in different cell types and protein samples, the 
proteomic studies using fatty acid chemical reporters in combination with CuAAC suggests that 
bioorthogonal ligation methods can have higher signal-to-noise (Figure 12)122. For example, ~1/4 
of proteins recovered from alk-FA labeling were also found in negative controls, whereas ~2/3 of 
proteins recovered from ABE experiments were recovered from samples not treated with 
hydroxylamine. With respect to the chemical linkage of fatty acid protein modification, fatty 
chemical reporters enable the analysis of N-myristoylated proteins and other potential sites of 
amino acid modification122 (Appendix Tables 1 and 2), whereas ABE selectively targets S-
acylated proteins186,188-190 and has enabled identification of site modifications189,190. Although the 
total number of proteins identified by ABE studies from three different protein sources was 
higher, the overlap with this study was not substantially greater (107 gene symbols versus 94 
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gene symbols;, see Figure 14 and Figure 15). Overall, both methods provide important insight 
into the diversity and biochemical properties of fatty-acylated proteins. 
 
Within all five studies, ~70% – 80% of proteins were observed in only one study (Figure 15 and 
Appendix Table 3), ~15% – 20% were observed in two studies, ~5% – 7% were observed in 
three and only 2% were observed in four studies. With the exception of some comparisons to 
Zacharias data, the overlaps of all studies were statistically significant for reasonable 
assumptions of the number of expressed proteins (Table 5). No proteins were observed in all 
studies, reflective of the different methods of analysis, sample preparation and protein sources. 
Of the high confidence lists only, C11orf59, Canx, FAM108B1, Gna13, Gnai2, Gnai3, Gnaq, 
Gnas, KIAA0152, Snap23, Tfrc and Txndc1 were shared among four studies; expanding this to 
include medium confidence hits, Cd81, Dnajc5, GNAO1, Igf2r, Rab1b, Rap2b, RPL12, Rpl5, 
RPS3A, Scamp3, SLC25A5 are also observed. The greatest overlap between studies both in 
number of shared gene symbols and percentage overlap was observed between the Cravatt and 
Freeman studies (35%, 127 symbols), followed by Cravatt and this study (28%, 94 symbols) and 
Davis and Freeman (27%, 100 symbols). The high degree of overlap between this study and 
Cravatt’s is likely due the same cell type (Jurkat T cells) and use of fatty acid chemical reporters. 
The Cravatt, Davis and Freeman datasets all analyzed membrane fractions of mammalian cells, 







Table 5 Statistical significance of overlap between studies for Figure 15 using a hypergeometric 
distribution with various assumptions of the number of active genes (expressed proteins). 5381 
proteins were identified by proteomics in the global survey of Jurkat T cells210. All pairs but the 
last are statistically significant even assuming 5381 (an underestimate) represents all proteins ex-








p-value for assumed expression of 
24,000 genes 12,000 genes 6,000 genes 5381 genes 3000 genes 
Cravatt, 
Freeman 35% 127 1.61E-142 3.31E-105 6.45E-69 2.23E-63 4.91E-35 
Cravatt, 
Hang 28% 94 5.48E-96 9.39E-69 1.10E-42 8.93E-39 2.58E-19 
Davis, 
Freeman 27% 100 3.57E-97 2.32E-68 5.63E-41 6.71E-37 6.23E-17 
Cravatt, 
Davis 23% 77 1.19E-70 1.00E-48 3.60E-28 3.71E-25 8.94E-11 
Freeman, 
Hang 19% 69 2.74E-54 3.42E-35 6.09E-18 1.60E-15 5.37E-05 
Davis, 
Hang 14% 49 3.93E-34 5.13E-21 1.09E-09 3.43E-08 0.0175887 
Hang, 
Zacharias 15% 29 1.01E-41 4.27E-33 1.40E-24 2.94E-23 2.66E-16 
Cravatt, 
Zacharias 6% 11 4.54E-11 5.59E-08 4.03E-05 0.0001044 0.0091529 
Freeman, 
Zacharias 5% 12 1.38E-11 3.14E-08 3.81E-05 0.0001055 0.0117337 
Davis, 
Zacharias 2% 3 0.026684 0.110640 0.229857 0.2321302 0.1071548 
 
Functional analysis of fatty-acylated proteins targeted by chemical reporters 
The large-scale analysis of proteins labeled with az/alk-FA chemical reporters of different chain 
lengths provides the opportunity to evaluate the specificity and diversity of protein fatty-
acylation in mammalian cells. To determine the specificity of protein labeling with az/alk-FA re-
porters, the protein hits identified from our proteomics experiments were sorted into groups 
based on the frequency of their recovery with different chain length of az/alk-FA reporters using 
normalized peptide spectral counts. A survey of the protein hits revealed many proteins were la-
78 
 
beled with multiple fatty acid chemical reporters (group VII) (Figure 11). In contrast, some pro-
teins were labeled in a chain length-dependent fashion (group I and III) (Figure 11). For exam-
ple, 44 proteins were only labeled by myristic analogs (az-12, alk-12) (group I) and 56 proteins 
were uniquely labeled by stearic acid analogs (az-15, alk-16) (group III). Many proteins labeled 
by alk-14 were targeted by shorter and longer fatty acid reporters (Figure 11), consistent with our 
previous observations that this fatty acid analog labels both N-myristoylated and S-palmitoylated 
proteins191. The fatty acid chain length labeling preferences were also evident by Western blot 
analysis of selectively recovered proteins (Figure 12A and B). N-myristoylated proteins such as 
ARFs were preferentially labeled by alk-12, whereas S-palmitoylated Ras was most efficiently 
recovered with alk-16 (Figure 12A). Alternatively, N-myristoylated and S-palmitoylated proteins 
such as Lck were recovered with multiple fatty acid reporters (Figure 12A). Other known S-
palmitoylated proteins such as the transferrin receptor did not reveal a significant preference for 
length of fatty acid reporters (Figure 12B). Differences in relative signal intensity of isoforms of 
the same protein between input and elution, such as with the transferrin receptor, likely represent 
preferential fatty-acylation of particular isoforms. 
Bioinformatic prediction of fatty-acylation of recovered proteins 
Analyzing our proteomic dataset with the N-myristoylation prediction program Myrbase183 
showed that high and medium confidence predictions were limited exclusively to proteins of 
groups I, II and III labeled by short-chain analogs (az/alk-12/alk-14) (Figure 11). At 0.49 ± 0.47, 
the average confidence of predicted myristoylation for these groups is statistically different from 
the average confidence for groups IV-VII (average = 0.03 ± 0.10; p = 1.16E-05, two-tailed heter-
oscedastic T-test). (Note that these averages represent a combination of confidence and frequen-
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cy of prediction, as the absence of predicted myristoylation is included and given a confidence of 
0. Thus, at ~0.5, all “average” proteins within groups I-III are predicted to be fully myristoylated 
with half maximum confidence, or alternatively, half are predicted to be myristoylated with max-
imum confidence and half are predicted to bear no myristoylation.) In contrast, the CSS-Palm 
prediction program based on previously reported S-palmitoylated proteins22 predicted fatty-
acylation of proteins throughout the dataset (Figure 11). Predicted palmitoylation showed little 
correlation with chain length of fatty acid analog and less statistical difference (confidence of 
predicted palmitoylation for groups I-III, 0.71 ± 0.42; confidence in groups IV-VII, 0.51 ± 0.51; 
p = 0.03, two-tailed heteroscedastic T-test). The less significant difference between groups I-III 
and IV-VII is likely not reflective of biological correlation but rather the bias of prediction from 
known motifs: only 45% of proteins in groups IV-VII have been reported by any study, whereas 
63% have been reported for groups I-III. Assuming that the average predicted confidence of 
palmitoylation based on known motifs scales linearly with the number of previously identified 
palmitoylated proteins, if 63% of proteins had been previously identified in groups IV-VII as 
they were for groups I-III, the average confidence of palmitoylation would increase to 0.70 and 
the statistical significance by the same test would increase to p = 0.90. Thus, palmitoylation pre-
diction was distributed more or less uniformly and did not correlate to any particular analog 
chain length. These results are consistent with the reported specificity of protein fatty-acylation, 
which found that NMTs preferentially utilize myristoyl-CoA through a relatively defined en-
zyme active site for N-myristoylation of proteins212, whereas S-acylated proteins typically con-




Annotation of subcellular location of identified proteins 
We evaluated the subcellular localization associated with proteins recovered from fatty acid 
chemical reporter labeling. It should be noted that protein samples from our studies represent an 
unbiased total cell lysates from lysis and solubilization using strong detergent (4% SDS) after 
nuclease treatment (benzonase), which eliminated the presence of any insoluble pellet. Our lysate 
thus includes nuclear, cytoplasmic, organelle and membrane proteins. Predicting protein locali-
zation for our dataset with the WoLF PSORT subcellular prediction algorithm215 revealed  that 
the majority of recovered fatty-acylated proteins are expected to be cytosolic (61%), with the 
remainder distributed to nuclei (17%), mitochondria (12%) and membranes (10%) (Figure 14D, 
Appendix Table 4A). Similar results were obtained from a corrected Bonferroni test for enrich-
ment of GO cellular component annotations of recovered proteins (p-value < 0.01). Cytosolic 
and cytoplasmic annotations were the most enriched (18% and 32% respectively) followed by 
mitochondrial (11%), nuclear (6%) and ribosomal annotations (2% – 6%) (Figure 16, Table 6). 
Annotated and predicted localizations contrast in particular for membrane and cytosol with re-
cent experimental data of Jurkat T cells generated by biochemical subcellular fractionation and 
proteomic analysis210. Based on that data, az/alk-FA-labeled proteins partition primarily in mem-
branes (50%), followed by cytosol (37%), nucleus (10%) and mitochondria (3%) (Figure 14E). 
The difference between the predicted and experimental subcellular localization suggested that 
many proteins predicted or annotated to be cytosolic may be membrane associated through fatty-
acylation. Interestingly, proteins recovered from total cell lysate were also significantly enriched 
in nuclear proteins (APEX1, HNRNPF, HNRNPH1, HNRNPL, DDB1, MCM2, MCM3, MCM6, 
NCL, PARP1, PCNA, PHB, PPP1CB, RANP1, RPS2, SUPT16H, UBC, XPO1, XRCC5, 
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XRCC6), suggesting that protein fatty-acylation could contribute to dynamic membrane target-
ing within the nucleus as well. 
 
 
Figure 16 Enriched GO annotations of cellular component, sorted by corrected p-value. 204 pro-
teins from high and medium confidences bore cellular component annotations and were tested 
with a Bonferroni and corrected Bonferroni test. At p < 0.01, recovered proteins were most en-
riched in cytosolic and cytoplasmic, ribosomal, nuclear, mitochondrial and ribonuclear proteins. 
 
 
Table 6  Enriched GO annotations of cellular component. Tabular data to Figure 16. Sorted by 




Function, biological processes and pathways of identified proteins 
The biological processes of proteins labeled with fatty acid chemical reporters were first exam-
ined manually (Figure 14F, Appendix Table 5), revealing that fatty-acylated proteins take part in 
wide range of cellular processes from signal transduction to protein synthesis and degradation. 
Statistical analysis of GO annotations using the Bonferroni correction (p-value < 0.01) revealed 
multiple enriched annotations within identified fatty-acylated proteins. Within molecular func-
tion, identifications were enriched in proteins that bind nucleotides, unfolded proteins and other 
proteins; proteins with GTPase activity and those binding GTP or ATP; proteins of the ribosome; 
and proteins which bind RNA (Figure 17 and Table 7). These molecular functions correlate well 
to enriched GO biological process annotations: most enriched were proteins involved with transi-
tional elongation (ribosomal proteins); protein folding, refolding and polymerization (processes 
requiring nucleotide, ATP or GTP binding); cellular component movement (ATP and GTP bind-
ing); several ubiquitin-dependent proteasome processes; and telomere maintenance (Figure 18, 
Table 8; appendix I). Finally, networks of functional association and protein-protein interactions 
within identified proteins were analyzed and visualized using STRING216, a database and data 
mining tool which distills a wide variety of information to confidences of protein interactions 
that are then clustered (Figure 19). A high confidence level of interaction (0.876), this analysis 
strikingly revealed tight associations within the large protein complexes of the ribosome (circled 
in blue), heterogeneous nuclear ribonucleoprotein complexes (hnRNPs, yellow), and the pro-
teasome (green). In addition to these highly pronounced associations, seven other major net-
works were also apparent involving: interrelated cytoskeleton components including 1) the tubu-
lins in particular and their regulatory molecules (highlighted in red); 2) actins and their regulato-
ry molecules (periwinkle), and 3) myosins (rose); 4) the 14-3-3 adaptor proteins which modulate 
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the activity of binding partners in a wide variety of signaling pathways (purple); 5) a large num-
ber of guanine nucleotide-binding proteins (G proteins, which serve to modulate or transduce 
transmembrane signal systems), connected with several membrane-bound kinases and members 
of the Ras family (brown); 6) an association of proteins involved in nuclear processes including 
DNA damage repair and maintenance, cell cycle progression, nucleoside metabolism and nuclear 
chaperonins (light green); and 7) enzymes of sugar metabolism including the interrelated glycol-
ysis/gluconeogenesis, fructose/mannose, pentose phosphate and pyruvate metabolic pathways 
(pink). Additional networks included nuclear transport (teal), mitochondrial electron transport 
(grey) and ATP synthesis (orange), and multiple DNA replication licensing factors of the highly 
conserved mini-chromosome maintenance proteins (MCM) involved in the initiation of eukary-
otic genome replication (light blue). Notably, HSP90α sat at the center of the interconnected 









Figure 17 Enriched GO annotations of molecular function, sorted by corrected p-value. 197 pro-
teins from high and medium confidences bore molecular function annotations and were tested 
with a Bonferroni and corrected Bonferroni test. At p < 0.01, recovered proteins were most en-
riched in proteins that bind nucleotides, unfolded proteins and other proteins, proteins with 






Table 7  Enriched GO annotations of molecular function. Tabular data to Figure 17. Sorted by 






Figure 18 Enriched GO annotations of biological process, sorted by corrected p-value. 194 pro-
teins from high and medium confidences bore cellular component annotations and were tested 
with a Bonferroni and corrected Bonferroni test. At p < 0.01, recovered proteins were most en-
riched in proteins involved with transitional elongation; protein folding, refolding and polymeri-
zation; cellular component movement; several ubiquitin-dependent proteasome processes; and 
telomere maintenance. See also Table 8 for complete descriptions. 
 
 
Table 8  Enriched GO annotations of biological process. Tabular data to Figure 18. Sorted by 







Figure 19 Functional and protein-protein interaction networks within identified fatty-acylated proteins of both high and medium con-
fidences. A STRING216 analysis of interactions at a high confidence level (≥0.876) revealed highly interconnected associations of 
three large protein complexes including the ribosome (circled in blue); heterogeneous nuclear ribonucleoprotein complexes (hnRNPs, 
yellow); and the proteasome (green). Seven other major networks were also apparent involving: interrelated cytoskeleton components 
including 1) the tubulins in particular as well as their regulatory molecules (highlighted in red); 2) actins and their regulatory mole-
cules (periwinkle), and 3) myosins (rose); 4) the 14-3-3 adaptor proteins which modulate the activity of binding partners in a wide va-
riety of signaling pathways (purple); 5) a large number of guanine nucleotide-binding proteins (G proteins, which serve to modulate or 
transduce transmembrane signal systems), connected with several membrane-bound kinases and members of the Ras family (brown); 
6) an association of proteins involved in nuclear processes including DNA damage repair and maintenance, cell cycle progression, nu-
cleoside metabolism and nuclear chaperonins (light green); and 7) enzymes of sugar metabolism including the interrelated glycoly-
sis/gluconeogenesis, fructose/mannose, pentose phosphate and pyruvate metabolic pathways (pink). Additional networks included nu-
clear transport (teal), mitochondrial electron transport (grey) and ATP synthesis (orange), and multiple DNA replication licensing fac-
tors of the highly conserved mini-chromosome maintenance proteins (MCM) involved in the initiation of eukaryotic genome replica-
tion (light blue). Note the presence of HSP90α at the center of the interconnected networks (red asterisks), closely flanked by HSP90β 







Correlation of fatty-acylation amd protein cysteine content 
Examination of the relationship between MS spectral counts and cysteine content of proteins 
identified in either positive fractions or negative fractions for both high and medium confidence 
levels revealed no correlation (R2 < 0.1) (Figure 20). Proteins with no or very low cysteine con-
tent were found to have relatively large numbers of spectral counts in both positive and negative 
enrichments. Likewise, proteins with higher cysteine contents exhibited both high and low signal 
in both enrichment sets. 
 
Figure 20  Total observed counts for proteins identified in high and medium confidences as a 
function of cysteine content. Top chart: proteins identified enriched in positive fractions, log 
scale. Bottom chart: proteins identified enriched in negative fractions, log scale, inverted. No 
significant correlation exists between cysteine content and total observed counts for either group. 
The insignificant correlation which does exist is negative for counts enriched in positive frac-
tions, reflecting decreased counts with increased cysteine content, and likewise positive for 





Unraveling the diversity of fatty-acylated proteins and the underlying regulatory mechanisms of 
protein fatty-acylation in eukaryotes is a challenging task. In this work, the large-scale identifica-
tion of fatty-acylated proteins from mammalian cells has been performed using azide/alkyne-
functionalized fatty acids from an unbiased, fully solubilized protein preparation. The enrich-
ment and proteomic analysis of proteins targeted by fatty acid reporters has revealed 57 known 
fatty-acylated proteins as well as 109 new candidate proteins (by gene symbol) with high confi-
dence that may be regulated by protein fatty-acylation; extending the list to include high and me-
dium confidence, this study identified 191 new candidate proteins and shared 154 identifications 
(Figure 15B and C). The comparison of azide- and alkynyl-fatty acid chemical reporters of vari-
ous chain lengths highlights the utility of both classes of lipid analogs for detecting fatty-acylated 
proteins as well as the selectivity of protein fatty-acylation in cells. 
Mechanisms of fatty-acylation 
The mechanism of fatty-acylation for proteins identified in our survey including histone H3 
could be due to chemical S-acylation (background reactivity, Figure 21A), substrate-mediated S-
acylation (auto- or self-acylation, Figure 21B), enzyme-catalyzed S-acylation (i.e. DHHC-PATs, 
Figure 21C), or some combination of these factors (Figure 21). At sufficient concentrations, co-
enzyme A activated fatty acids are capable of spontaneous chemical S-acylation on cysteine resi-
dues of proteins (GAPDH217; SNAP-25218; tubulin219,220; rhodopsin221; G protein α subunits222; 
myelin proteolipid protein (MPP)223; actin, lactate dehydrogenase, fetuin224; Bet3225) and also 
short peptides containing the natural site of protein palmitoylation224,226. Many of the proteins 
demonstrated to undergo chemical acylation are also substrates for PATs (SNAP-25227; tubulin 
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and G protein subunits220; rhodopsin221) and many also undergo catalytic self-palmitoylation 
(GAPDH228, SNAP-25218, MPP223, Bet3225). Likewise, DHHC-PATs load themselves prior to 
palmitoyl transfer through an auto-acylation event229. Auto-S-palmitoylation can occur in a regu-
lated fashion such as in response to fatty acid levels (GAPDH217) or protein-protein interactions 
(SNAP-25 palmitoylation is 100-fold greater when bound in the SNARE complex218; likewise, 
the presence of Gβγ enhances Gα palmitoylation222). This combination of mechanisms has com-
plicated analysis of the regulation of S-palmitoylation. 
 
S-acylation depends on two factors: the concentration of activated CoA ester and the relative re-
activity of the cysteine. Reactivity depends on chemical accessibility and the concentration of 
thiolate anion capable of a nucleophilic attack, which is enhanced by physical proximity to basic 
residues225,230-232 (Figure 21B and C). For DHHC-PATs, mutation of the cysteine-proximal basic 
residues (aspartic acid and histidine) sharply reduces or abrogates transferase activity229,233. Lo-
cal concentration of fatty acid-CoA, and thus acylation, is favored by hydrophobic residues near 
a site of modification230,234; similarly, DHHC-PATs can place a bound fatty acid at a specific res-
idue. Within mammalian cells, the global concentration of activated free fatty acids is kept to 
low nanomolar concentrations by the presence of acyl-CoA binding protein (ACBP)235,236. Be-
cause most studies of chemical acylation have not included ACBP and have extended the con-
centration of activated fatty acids even into the millimolar range, their results must be interpreted 
cautiously. Upon the inclusion of ACBP, chemical acylation of peptides and proteins can be 
eliminated; this buffering does not affect DHHC-PAT activity224,235,237 and the effect on self-








Figure 21 Mechanisms of protein S-acylation (palmitoylation). Mechanisms are not exclusive 
and may occur simultaneously. A) Chemical modification between coenzyme A activated fatty 
acids and cysteine-containing proteins (blue) can occur at sufficiently high concentration of fatty 
acid-CoA. In most of the cell, acyl-CoA binding protein (ACBP, green) normally buffers activat-
ed fatty acids to the low nanomolar range, quenching this mechanism. However, in mitochon-
dria, chemical modification may play a greater role. B) Catalytic substrate-mediated (or auto- or 
self-acylation) occurs for a number of proteins, including DHHC-PATs, where the reaction pre-
pares the PAT for palmitoyl transfer to other proteins. S-acylation is assisted by cysteine proxim-
ity to basic residues, which favor formation of a thiolate anion, and proximity to hydrophobic 
residues, which favor increase local concentration of fatty acid-CoA. DHHC-PAT activity is un-
influenced by ACBP; the effect of ACBP on other self-acylating proteins has not been studied. 
Protein-protein interactions can greatly influence the rate of auto S-acylation. C) Enzymatic 
DHHC-PAT-mediated palmitoylation likely occurs via a similar mechanism and many proteins 
that show self-modification are PAT substrates. A catalytic base is shown and might belong to 
either the DHHC-PAT (purple) or substrate protein. PAT specificity results from distinct PAT-
protein interactions. The exact mechanism of DHHC-PAT-mediated palmitoylation remains a 




Other possible mechanisms of fatty-acylation 
In addition to the cellular mechanisms of Figure 21, post-lysis acylation could result from dis-
rupting ACBP binding, releasing activated fatty acids, and the simultaneously exposure of buried 
free cysteines such as C110 of H3 variants. The extent of this reaction will depend on the con-
centration of CoA activated fatty acid; in the case of click chemistry analysis, the relative con-
centrations of clickable and native fatty acids; the concentrations of protein; the relative concen-
tration of other thiols such as glutathione; and finally the time and temperature before small mol-
ecules are removed from lysate proteins, e.g. by precipitation. No studies of protein fatty-
acylation to date have addressed this possible mechanism and specific strategies to elucidate its 
potential contribution are described below in Future Directions. 
Fatty-acylation does not correlate to protein cysteine content 
While post-lysis modification with fatty acids cannot be excluded without additional experimen-
tation, the prevalence of such a mechanism would favor higher recovery of proteins with high 
cysteine content. No significant correlation was found between cysteine content and MS counts 
(R2 < 0.1) (Figure 20). The poor correlation that does exists for positive counts in excess of nega-
tive is negative, reflecting a decreased overall signal with increased cysteine content, and the 
small correlation between negative counts in excess of positive is positive, reflecting decreased 
signal in negative samples with increasing cysteine content. Cysteine content alone is thus un-
predictive of enriched peptide counts, suggesting that post-lysis does not significantly contribute 
to recovered signal. However, this represents and overall trend and in particular for proteins such 
as H3, in which a free sulfhydryl is known to be maintained and which is present in large quanti-
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ty, exceptions may be present. Further experimentation will shed light on this possibility (see Fu-
ture Directions). 
Possibility of “in vivo chemical fatty-acylation” 
In addition to the mechanisms of Figure 21 and ex vivo post-lysis chemical acylation, the possi-
bility for a sort of “in vivo chemical palmitoylation” exists for enzymes with highly reactive 
functional groups, in particular (but not exclusively) cysteine sulfhydryls. Such reactive func-
tional groups are abundant in enzymes with oxidoreductase activity, such as the peroxiredoxins, 
and are also present in enzymes subject to redox control like the serine/threonine protein phos-
phatase-1 subfamily238. The active nature of these sulfhydryls presents the possibility of an al-
most immediate reaction with any nearby molecules of activated CoA esters; if depalmitoylation 
is kinetically slower, a palmitoylated state would be favored. Such “background” chemical acyla-
tion might be purposeful, as for the regulation of GAPDH activity, or alternatively might repre-
sent true background chemical reaction within the cell cleared either by intrinsic activity or an 
extrinsic enzyme. Notably, five of six peroxiredoxins were identified in this dataset, multiple 
members of the protein phosphatase-1 family and over 20 proteins bearing annotations of redox 
activity (see Table 9). One of the few proteins found to be common to four studies, thioredoxin 
domain-containing protein 1, was also identified, suggesting this mechanism could be wide-
spread. Most of these proteins displayed a preference for fatty acid chain length, either long or 
short, and while this behavior would be unexpected in the denatured state, such preferences can 
be easily interpreted as the result of unique protein properties such steric accessibility or size and 
layout of hydrophobic and electrostatic interactions. Many of these proteins or their relatives 
were also detected in ABE experiments performed on rat brain tissue (Appendix Table 3), sug-
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gesting that detection of such reactive proteins is not unique to cell culture or click chemistry. 
However, as with post-lysis modification, analysis of the possibility of in vivo chemical modifi-
cation of reactive proteins will require further experimentation. The question would best be ad-
dressed by monitoring possible a reaction in vitro between purified proteins, such as those of Ta-
ble 9, and a traceable fatty acid analog CoA-ester (radioactive or clickable) at low concentration 
preferably in the presence and absence of ACBP. Increased modification with time would pre-
sent strong evidence that this mechanism occurs in vivo. Modification to unity would reflect ex-
trinsic de-acylation while an equilibrium state of partial fatty-acylation indicates the proteins 

















Table 9 Proteins identified in this work annotated to have redox function. 
 
Protein name Symbol 
APEX nuclease (multifunctional DNA repair enzyme) APEX1 
C-1-tetrahydrofolate synthase, cytoplasmic MTHFD1
Cytochrome c oxidase subunit II COX2 
D-3-phosphoglycerate dehydrogenase PHGDH 
Glutamate dehydrogenase (NAD(P)+) GLUD1 
Hydroxyacyl-Coenzyme A dehydrogenase, type II HADH2 
Isocitrate dehydrogenase [NADP], mitochondrial IDH2 
Lactate dehydrogenase B LDHB 
Malate dehydrogenase, mitochondrial MDH2 





Peroxiredoxin-5, mitochondrial PRDX5 
Protein disulfide-isomerase PP4HB 
Protein disulfide-isomerase A3 PDIA3 
Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) SDHA 
Synaptic vesicle membrane protein VAT-1 homolog VAT1 
Thioredoxin domain-containing protein 1 TXNDC1
Trifunctional protein alpha-subunit HADHA 
 
Chain length preference in fatty-acylation 
Preference for particular fatty acid chain lengths was seen dramatically for proteins such as 
ARFs, RAS or coronin 1A (Figure 12), but not for others such as VCP or Lck. Several factors 
likely combine to result in such biases. Enzymatically, both NMTs and DHHC PATs have been 
shown to have relatively broad substrate recognition centered on myristic acid (14 carbons176) 
and somewhere around palmitic and stearic acids (16 – 18 carbons216), respectively. Especially in 
 96 
 
the case of dual myristoylation and palmitoylation, such as for Lck, no particular chain length 
preference is expected and none was observed. Likewise, for proteins bearing a sole myristoy-
lation, as for the ARFs, a strong preference for myristic acid analogs is expected and was ob-
served (Figure 12). In the case of palmitoylation by DHHC-PATs, while substrate chain length 
preference has been observed in competition experiments216, the unknown enzyme structure and 
modification mechanism leaves multiple questions for the many mammalian transferases. First, 
the fatty acid substrate specificity of distinct PATs remains unknown and may be PAT-specific, 
perhaps controlled at their loading step. Second, the protein substrate specificity of loaded PATs 
remains unresolved. Thus, the chain length preference shown by Ras could be explained by mod-
ification with one or more PAT preferring a longer chain length, while likewise, the lack of spec-
ificity seen for VCP could reflect modification with PATs showing reduced specificity, or even 
modification by PATs with enhanced recognition of shorter chain lengths. Third, in addition to 
the affinities between PATs and their protein substrates, the protein to be acylated could interact 
with the specific fatty acid loaded on the transferase to foster or discourage binding and thus S-
acylation. For example, by sterically protruding into a region filled by longer, but not shorter, 
fatty acids, protein substrates could be preferentially modified by binding PATs bearing shorter 
length fatty acids. Analogous interactions might exist for preference of longer chain lengths. 
PAT protein substrates may thus themselves provide an additional level of chain length prefer-
ence in addition to the preference of the modifying PAT(s). For auto-acylation including PAT 
loading, hydrophobic, electrostatic, hydrogen bonding and steric interactions will govern sub-
strate binding and result in energetic preference for some particular chain length; in the case of 
desaturation or similar chain length, preference may be very close, as previously described216. 
Finally, fatty-acylation of all types will be subject to simple stoichiometry: given a large enough 
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excess of a non-ideal chain length, incorporation of that fatty acid will be favored even in the 
presence of better substrates. 
Metabolic modification of fatty-acid analogs 
Due to the terminal position of their functionalization, both alkyne and azido fatty acid analogs 
are likely subject to catabolic and anabolic processes. Over time, these processes may alter the in 
vivo composition of analog chain length. This possibility is supported by the detection of many 
known myristoylated proteins after overnight incubation with alk-16122. Likewise, ARF modifi-
cation with palmitic or stearic acid analogs was detected in this work (Figure 12), although with 
substantially reduced signal. Both enzyme substrate tolerances and metabolic processes could 
explain these observations. However, the strong influence of analog chain length on recovered 
signal for proteins like the ARFs indicates that metabolic exchange did not equalize the chain 
lengths of added analogs within the experimental timescale. The exact nature of fatty acid me-
tabolism may be complex and will depend on time and metabolic state. For example, catabolism 
will be favored under conditions of limited energy or high metabolic demand. Similarly, given 
sufficient energy, added analog chain length will likely be subject redistribution towards the fatty 
acid chain length equilibrium of the cell. Other sources of fatty acids, such as from cell culture 
sera, will also influence this redistribution. Thus, outwardly similar experimental conditions may 
yield potentially unexpected differences in metabolism. However, within study of protein fatty-
acylation, the effect of metabolism may be minor: given sufficient sensitivity, the reduced yet 
present incorporation of non-optimal chain lengths for a given fatty acid transferase will always 
be observed and the substrate tolerance of myristoylation and palmitoylation machinery216176 in-
dicates that the biological effect of two more or two less carbons is not substantial. This may be 
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especially true for fatty-acylation: in contrast to incorporation of amino acids or nucleotides, fat-
ty acids from 12-20 carbons have relatively similar properties within an aqueous environment. In 
addition, because lipidated proteins often bear multiple lipid modifications, the effect of small 
differences in chain length will often be diluted. The chain length preferences of NMTs and 
PATs may thus not reflect overall requirements of hydrophobicity but rather the evolution of sys-
tems of control (constitutive and dynamic). Teasing out the contribution of metabolism on added 
fatty acid analogs will be most easily accomplished by MS analysis of the modified peptides to 
establish the fatty acid composition. Such detail will also provide insight into the proportion of 
modification. Until such experimentation, at least within the conditions of this work, the observa-
tion of substantial chain length preference of particular proteins for both short and long chains 
indicates that metabolic exchange did not equalize the concentration of myristic to stearic acid 
analogs and all proteins predicted to be myristoylated with high or medium confidence fell with-
in the groups modified by myristic acid (Figure 11). 
General implications for fatty-acylation and its study 
Given the unbiased approach of this survey and the discovery of fatty-acylated proteins through-
out diverse cellular compartments, the best conclusion might well be “What does it mean?” and 
the next perhaps “What is the next study?” These questions can be neither quickly dismissed nor 
quickly addressed, and their accurate answer lies in much future experimental work. However, 





Figure 2 represents the prevailing view of fatty-acylation: the modification, which can be dynam-
ic in the case of palmitoylation, results in membrane association of proteins from a wide variety 
of membrane-related processes and regulates protein function by controlling subcellular location. 
This view is not incorrect and, in Figure 19, is reflected in the tight networks of G-proteins and 
14-3-3 adapters. Both protein families are known to be heavily involved in signaling and signal 
modulation at the membrane. Despite these two similarities, Figure 2 and Figure 19 are strikingly 
different. In particular, Figure 2 bears no mention of the cytoskeleton, which must interface by 
some mechanism with membranes throughout the cell; it illustrates the nucleus but reports no 
role for fatty-acylation in any nuclear process, and likewise it shows no role of myristoylation or 
palmitoylation in metabolismii or protein complexes, in particular the ribosome and proteasome, 
nor within complexes of mitochondria. Statistical analysis of GO annotations shows that the pro-
teins identified in this work support the networks of Figure 19. Enriched cellular component an-
notations include cytosolic, nuclear, mitochondrial, ribosomal and ribonuclear proteins (Figure 
16 and Table 6; note that cytoskeletal proteins are annotated as cytosolic), in good agreement 
with the networked clusters. Correspondingly, enriched biological process annotations include 
translational elongation, protein polymerization, cellular movement (which includes cytoskeletal 
proteins and their regulators) and telomere maintenance (Figure 18 and Table 8). Protein folding 
and refolding processes were also statistically overrepresented, matching the central, chaperon-
surrounded HSP90α hub of Figure 19 (marked with a red asterisks). Enriched molecular func-
tions reflect these biological processes and include binding of nucleotides and RNA, proteins and 
unfolded proteins, ATP or GTP, as well as GTP hydrolysis (Figure 17 and Table 7). Thus, this 
                                                 
ii Notably, GAPDH has the largest number of connections within the metabolic network (10 spokes) and was found 




work first suggests broader involvement of fatty-acylation in cellular processes and subcellular 
localizations than is currently appreciated. 
 
Behind the disparity in overviews of Figure 2 and Figure 19 lies the influence and importance of 
sample preparation in the study of fatty-acylation: of the five current global studies of protein 
acylation, only this work analyzed fully solubilized cells while the other four employed mem-
brane preparations, continuing a historical trend. For decades, membrane fractionation and mild 
detergent solubilization (RIPA, NP40, Brij, etc.) have been a common first step in the study of 
fatty-acylated proteins239,240 despite the fact that both techniques leave behind large, undissolved 
and typically unanalyzed pellets. Data from the global proteomics survey of Jurkat T cells210 
yield a sense of the compositional difference between the lowly pellet and membrane fractiona-
tion. Within the 5381 proteins confidently identified, 25% were common to membrane and cyto-
solic fractions, 27% to membrane and nuclear fractions and only 14% were detected in all three 
fractionations. Well correlating to these proportions, 17% – 26% of fatty-acylated proteins were 
shared in common between this study and that of Cravatt122 which employed a closely similar 
experimental approach with membrane fractionation of the same cell line as this study, and this 
study identified a total of 101 more proteins. Thus, this work secondly indicates the examination 
of proteins from membrane fractionation has left undetected large populations of proteins present 
in subcellular locations other than membranes. Discoveries have consequently converged on a 





Figure 22  Enriched GO annotations of cellular component for full Cravatt dataset122, sorted by 
corrected p-value. 133 proteins identified bore cellular component annotations and were tested 
with a Bonferroni and corrected Bonferroni test. Three components were enriched at p < 0.01. 
 
 
Table 10 Enriched GO annotations of cellular component for full Cravatt dataset122. Tabular data 
to Figure 22. Sorted by corrected Bonferroni p-value.  
 
 
Supporting this conclusion, different sample preparations from the same cell line identified pro-
teins from different cellular compartments and membrane fractionation yielded fewer statistically 
significant enrichments of cellular component. Repeating the analysis of Figure 16 and Table 6 
for the full Cravatt dataset (Figure 22 and Table 10), three enrichments of cellular component 
were apparent versus nine for this work and the average statistically significance of enrichment 
was 16-fold lower (average corrected p value = 1.28 E -4 for this work vs. 2.01 E -3 for the Cra-
vatt dataset). Only enrichments of cytosolic annotations were common to this study and compo-
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nents of the membraneous Golgi apparatus were statistically overrepresented. The contrast in 
type and number of cellular component enrichment is first partially reflective of statistics. Within 
the proteins of this study, a similar yet smaller number of proteins were annotated to be part of 
the proteasome complex (5 vs. 7) and Golgi apparatus (15 vs. 19) but due to the lesser represen-
tation and the larger sample size of this dataset (361 vs. 260 proteins), these annotations did not 
reach statistical confidence. Second and more significantly, the differences in enrichment reflect 
the breadth and depth of sampling. Membrane preparation presents only the membrane-
associated proteins of any given cellular component, hindering the identification of cellular com-
ponents which contain protein members not bound to membranes. In the same way, the prepara-
tion favors enrichment of fully membraneous cellular components like the Golgi. For Jurkat T 
cells, these factors combined to yield a three-fold lower number of cellular component enrich-
ments overall yet also new enrichments reflective of membrane preparation enrichment. Thus 
thirdly, this work suggests that analysis of the fraction(s) remaining after a membrane prepara-
tion could addess the bias of sample preparation while simultaneously maintaining enhanced de-
tection of low-level membrane bound proteins. 
 
A comparison of the 52 proteins shared in common between the two studies (or 82 considering 
possible subhit interpretations; see Appendix Table 3) to the dataset as a whole verifies the bias 
introduced by membrane fractionation. Compared to the full cohort (Figure 14F) in which 10% 
of proteins are predicted to be membrane bound and 50% were experimentally observed in 
membrane fractions, 14-18% of the shared 52-82 proteins are predicted to be membrane bound 
and 51-56% were experimentally observed (Figure 23). The skew towards a higher membrane 
composition is expected given the membrane preparation used in the comparison study. Cellular 
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component annotations of the common 52 proteins (Figure 24, Table 11) share statistical en-
richment of cytosolic, cytoplasmic and ribosomal annotations with the full dataset; these annota-
tions are often associated with membranes as shown by Figure 14 and Figure 23. However, dis-
tinctly missing from enriched annotations are non-membrane cellular components such as the 
nucleus and mitochondria. These differences are echoed by changed annotation enrichments of 
molecular function and biological processes (Figure 25, Figure 26, Table 12, Table 13): while of-
ten membrane-bound translational and ribosomal annotations remain enriched, others like cellu-
lar movement (i.e. cytoskeleton) are lost. Correspondingly, molecular functions like GTP bind-
ing and GTPase activity are no longer enriched but those common among membrane proteins, 
such as protein and nucleotide binding ubiquitous for G-protein subunits, remain. Due to the 
small sample size, multiple statistically significant enrichments are present for processes with 
small numbers of members. However, while the presence within 52 proteins of one member of a 
two-member annotation set is statistically significant (Figure 24, Figure 25, Figure 26, Table 11, 
Table 12, Table 13), meaning beyond the presence of fatty-acylation for that protein is tentative. 
Thus, the proteins shared with the Cravatt study are expectedly enriched in membrane bound 
proteins and often bear cytosolic and ribosomal annotations. Reflective of membrane selection, 
the common proteins lack cellular components, molecular functions and biological processes as-







Figure 23 Predicted and observed subcellular location for proteins common to the data of this 






Figure 24  Enriched GO annotations of cellular component for the 52 proteins shared between 
this and the Cravatt studies, sorted by corrected p-value. 32 proteins identified bore cellular 
component annotations and were tested with a Bonferroni and corrected Bonferroni test. Six 
components were enriched at p < 0.01 including those of the cytoplasm and ribosome. Con-
trasting the full dataset, component annotations of mitochondria and nuclei are not longer pre-
sent. Given the small sample size, components with small numbers of annotations are statistical-
ly significant if only one member of the set is present (see also Table 11). Such enrichments may 




Table 11 Enriched GO annotations of cellular component for the 52 proteins shared between this 






Figure 25  Enriched GO annotations of molecular function for the 52 proteins shared between 
this and the Cravatt studies, sorted by corrected p-value. 29 proteins bore molecular function an-
notations and were tested with a Bonferroni and corrected Bonferroni test. At p < 0.01, recovered 
proteins were most enriched in proteins that bind nucleotides and proteins, and those involved in 
translation including the ribosome. See also Table 12 and note regarding enrichment of annota-
tions with few members in Figure 24. 
 




Table 12 Enriched GO annotations of molecular function for the 52 proteins shared between this 






Figure 26 Enriched GO annotations of biological process for the 52 proteins shared between this 
and the Cravatt studies, sorted by corrected p-value. 30 proteins bore biological process annota-
tions and were tested with a Bonferroni and corrected Bonferroni test. At p < 0.01, translational 
elongation remained. See also Table 13 and note regarding enrichment of annotations with few 





Table 13 Enriched GO annotations of biological process for the 52 proteins shared between this 





In addition to sampeling proteins outside a membranous environment, the complete solubiliza-
tion strategy employed here contributed in a second manner to the identification of previously 
unidentified fatty-acylated proteins and protein networks. Observation of fatty-acylation on high-
ly abundant, often sticky proteins such as those of the ribosome, cytoskeleton and metabolic en-
zymes has often been obscured by difficulty in distinguishing genuine bound signal from back-
ground binding to beads. This limitation results from wash conditions insufficient to effectively 
remove plentiful proteins and can easily result in false negative assignments. Wash conditions 
typically present an experimental challenge: a balance must be struck between loss of proteins of 
interest and background binding. However, the combination of click chemistry with biotin cap-
ture presents one of the few experimental systems amenable to extreme stringency of wash. This 
harshly solubilizing detergent conditions used in this work during labeling and capture (0.5% – 
4% SDS) combined with highly stringent washes (2% SDS, 8 M urea, 2.5 M NaCl and more) en-
abled reliable identification of abundant ribosomal, cytoskeletal and metabolic proteins. Under 
these conditions, weak but dectable background was still observable for abundant proteins like 
actins and tubulins, heat shock proteins and some metabolic enzymes (enolase and phospho-
glycerate kinase, see Figure 11) but similar background was not observed for ribosomal, mito-
chondrial or proteasomal proteins. Western blotting for multiple proteins confirmed the lack of 
background binding and, in the case of HSP90, revealed MS detection of background binding to 
be more sensitivity than ECL at that exposure (Figure 11, Figure 12, Figure 13). Thus forthly, 
this work presents an experimental approach which enables distinction of true signal from high 




As with all research, discoveries within fatty-acylation have flowed from the solubilized proteins 
of a sample. Major complexes and networks, in particular tightly-packed chromatin of the dense 
nucleus, as well as the cytoskeleton and others, are not brought into solution with typical ap-
proaches. They have thus remained largely or fully unexamined. In addition, the use of mem-
brane preparations, while they enrich membrane-associated low-level proteins, has directed our 
view of fatty-acylation to a membrane-centric view. Multiple reviews summarize similarly to 
“Whereas kinase and phosphatase activity generally acts by directly modulating protein-protein 
interactions, palmitoylation is more likely to achieve its affects via regulation of protein-
membrane interactions”241 yet neglect to mention that other cell regions have been examined 
minimally at best. Overarchingly, the implication of this wok is that fatty-acylation is present 
throughout the cell, rather than one restricted to membrane-associated proteins, and plays a role 
in diverse processes from metabolism and energy production to protein maintenance and folding 
to the cell cycle. 
 
If, then, fatty-acylation is so widespread, what is its role? We can best understand its broader im-
plications first principles. Like hydrophobic sections of proteins, the addition of fatty acids can 
certainly serve to generate membrane affinities, but they can also serve to create intra- or inter-
molecule affinities. Hydrophobic interactions underlie protein and protein-complex stability (in-
cluding that of histone octamers) and lipidation, in particular dynamic palmitoylation, represents 
an efficient mechanism to modulate hydrophobicity. This modulation can change interactions 
within proteins, altering conformations and thus activities, as well as between proteins. In addi-
tion, lipid modifications alter chemical reactivity by capping a sulfhydryl, hydroxyl, amine or 
other functional groups; this change may result in alterations in catalytic activity of enzymes. 
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Thus, like phosphorylation, fatty-acylation and in particular dynamic palmitoylation is a regula-
tory PTM with the ability to modulate interactions and activities. 
 
Many examples of fatty-acylation modulating hydrophobicity, altering interactions and changing 
activity are known. These examples extend to the generation of membrane affinity – for exam-
ple, the catalytic efficiency of signaling cascades is effected by close physical proximity brought 
about by membrane-bound clustering – but are much more diverse. In the case of single proteins, 
constituitive S-acylation discovered crystallography on auto-palmitoylating Bet3 was shown to 
be essential to structure and function by providing internal, stabilizing hydrophobic interac-
tions225. In contrast to a structural role, dynamic palmitoylation regulates protein activity of 
GAPDH in response to metabolic state217. Palmitoylation regulates protein-protein interactions 
outside effects on membrane association. Such effects have been studied in particular for the 
large network of tetraspanins. Abolishion of palmitoylation from integrin β4 diminished associa-
tions with tetraspanins CD9, CD81, and CD63, without changing behavior in membrane density 
fractionation, lipid raft association or detergent solubility242. Similarly, elimination of pal-
mitoylation in CD151 had minimal influence on density fractionation and detergent solubility but 
resulted in significantly less association with CD9 and CD63243. Likewise, palmitoylation-
deficient mutants of CD81 show impared interaction with CD9 and EWI-2244. In contrast, pal-
mitoylation of CD9 actually inhibits association with EWI-2 and unmodified proteins are prefer-
entially bound245. Palmitoylation is therefore required for the correct assembly and structure of 
the large tetraspanin network often coined the “tetraspanin web”243. While this network is local-
ized to the cell surface, note should be made that palmitoylation does not appear to cause or alter 
membrane association. Fatty-acylation status also regulates N-type calcium channel activity 
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through modulation of protein-protein interactions. Palmitoylated splice variants of regulatory β 
subunits are stimulated by Gq while unmodified forms are inhibited by the same protein246. The 
function of palmitoylation thus extends far beyond simple membrane affinity, although this ef-
fect remains important. Modification by palmitic acid can modulate protein activity; can modu-
late intraprotein interactions altering stability and conformation; and can modulate protein-
protein intereactions of quartenary structures by either enhancing or inhibiting binding.  
 
While the tetraspanins represent a very large, if diffuse, complex, the role palmitoylation plays in 
spatiotemporal regulation of other large, multi-member and dynamic protein complexes remains 
a tantilizing area of future research. Most notable in Figure 19 is the preponderance of such net-
works and assembelies. Representation is extensive and includes the ribosome, proteasome and 
cytoskeleton; metabolic and mitochondrial complexes; and multiple assembelies with DNA and 
RNA association such as DNA replication licensing factors and heterogeneous nuclear nibonu-
cleoprotein complexes. Each of these assemblies undergoes dramatic changes depending on cel-
lular state and fatty-acylation likely plays a major role in their dynamic nature. However, the 
study of such protein networks and complexes will warrent techniques outside genetic mutation: 
the number of proteins and possible sites of modification combine exponentially to make a brute 
force approach of this strategy intractable. Further investigation will also likely reveal multiple 
roles for activity regulation by fatty-acylation as has been shown for GAPDH. Given the intimate 
connection between fatty-acids and key metabolic intermediates, as well as the presence of many 
glyclytic enzymes in this and other datasets (see Figure 11, Figure 14 and Figure 19), pal-
mitoylation probably also regulates the activity of multiple metabolic enzyme. Overall, fatty-
acylation and palmitoylation will increasingly be shown to have major roles in intra- and intre-
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protein interactions, and in control of catalytic activity, particularly in the regulation of metabo-
lism. 
Histone H3 fatty-acylation 
The discovery of S-fatty-acylation on histone H3 variants represents a new type of histone modi-
fication whose implications will require further study. In particular, mechanism of fatty-acylation 
(Figure 21), dynamics, stability and overall function remain open questions. Cys110 of H3 vari-
ants lies buried deep within the nucleosome at the end of the H3 α-2 helix, occupying the center 
of a four-helix bundle at the H3-H3’ interface between the two H3-H4 dimers of the (H3-H4)2 te-
tramer. Through hydrophobic interactions and hydrogen bonds, this region alone causes tetramer 
formation247-250. Disrupting the hydrophobic surfaces with a C110E mutation results in obligato-
ry H3-H4 dimers251. Without denaturation, C110 is chemically inaccessible to a wide variety of 
sulfhydryl reactive reagents conditions252-255. The involvement of this residue in chromatin struc-
ture has been long discussed in the context of an H3-H3 disulfide256,257. However, four separate 
crystallographic studies, including one under oxidative conditions, have shown intersulfur dis-
tances in assembled nucleosomes to be incompatible with a disulfide linkage247-250. Indeed, this 
residue has been shown to become chemically accessible only during active gene transcription258-
260. Additionally, in HPLC histone purifications, small quantities of hydrophobic (late-eluting) 
species are observed after the main H3 peak261, possibly representing the presence of fatty-
acylated H3 species. 
 
Cytosolic H3 modification including acetylation or methylation by early acting enzymes prior to 
chromatin incorporation has been demonstrated262,263 and given the ER and perinuclear localiza-
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tion of multiple DHHC-PATs264, it is possible H3 variants are modified before nuclear incorpo-
ration, during nuclear breakdown or possibly at the periphery of the nucleus during specific regu-
latory events (Figure 27). The lack of chain length dependence (Figure 11 and Figure 12) could 






Figure 27 Possible roles of histone H3 acylation. The function of histone H3 acylation remains 
to be determined and for heterochromatin, might be involved in direct tethering to the nuclear 
envelope or tethering through a new protein-protein interaction. If involved in euchromatin, H3 
acylation might play a role in a new protein-protein interaction. The dynamics, mechanism and 





Functionally, the S-fatty-acylation of histone H3 variants might, like methylation and acetyla-
tion265, alter nuclear events by establishing a binding platform for effector proteins like histone 
chaperones (Figure 27). Alternatively, S-palmitoylation could affect the properties of chromatin 
itself, perhaps resulting in new, stabilizing hydrophobic interactions within one or between sev-
eral nucleosomes, or nucleosomes and other chromatin proteins. Palmitoylation might also play a 
role in the sub-organellular structure of the nucleus including spatial and functional compartmen-
talization of proteinaceous nuclear bodies, and chromatin domains and territories266,267. PTMs in-
cluding methylation and acetylation show distinct nuclear localization, which can change with 
tissue type, cellular state and cell cycle268. Such PTMs are well established to modulate gene ac-
tivity by changing higher-order nuclear organization. For example, the addition of active chro-
matin marks like H3K9 acetylation or H3K4me2 results in chromatin decondensation and the 
formation of chromatin loops269. Whether S-palmitoylation is involved in the regulatory protein-
protein interactions of subnuclear organization remains to be seen. Particularly tempting is the 
potential involvement of S-palmitoylation in perinuclear tethering of chromatin to the nuclear 
envelope (Figure 27), a localization generally associated with inactive heterochromatin and gene 
silencing266,267. Indeed, H3 variants are enriched in the nuclear shell fraction of HeLa cells270. 
While such localization might involve interaction with the nuclear membranes, it also could be 
protein specific. H3 has been shown to interact with membrane-bound lamin B-receptor 
(LBR)271 and BAF (barrier-to-autointegration factor)272, which in turn bind multiple inner nucle-
ar membrane proteins273,274. In addition, carboxyl-terminal tails of nuclear lamins bind H3275. 
Given the dynamic nature of S-palmitoylation20, it will be interesting to determine the status of 
C110 palmitoylation (and potentially H3.1 C96) in conjunction with other PTMs, through the 
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cell cycle and under various states, as well as the relative levels of modification between the H3 
variants and their localizations. 
 
Conclusion 
Deciphering the function, regulation and meaning of protein fatty-acylation will be an exciting 
field for years to come. This survey of proteins and others demonstrate that many more cellular 
proteins are modified with fatty acids than previously appreciated. Using fully solubilized mam-
malian cells, we discovered S-acylation of histone H3 variants. The highly conserved Cys110 
was determined by site-directed mutagenesis to be the site of modification for H3.2; the function 
of this PTM remains to be elucidated and may be involved in perinuclear chromatin silencing. 
The large-scale identification of fatty-acylation sites on proteins remains a significant challenge 
and will be essential for dissecting the functional roles of protein fatty-acylation in various cellu-
lar pathways. The characterization of specific acyltransferases and lipases responsible for indi-
vidual fatty-acylated proteins will be key to determining their functions.  
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DIRECT VISUALIZATION OF CHOLESTEROL 
 
Introduction 
In humans and other vertebrates, cholesterol is essential to life and plays a critical role in disease 
and healthy physiology276. Eukaryotic cells have complex mechanisms to sense cholesterol levels 
and regulate its synthesis and trafficking277. Defects in cholesterol homeostasis are responsible 
for diseases such as familial hypercholesterolemia or atherosclerosis278, and neurological condi-
tions like Niemann-Pick disease276; low brain cholesterol is also associated with autism spectrum 
disorders279. Within membranes, cholesterol regulates permeability, fluidity and mechanical 
strength, and it is a major component of detergent-resistant microdomains (lipid-rafts)276,280,281. 
Cholesterol content in membranes affects protein sorting and activity of membrane pro-
teins276,280,281. Cholesterol is a ligand for some proteins and many of its derivatives are signaling 
molecules (e.g. steroid hormones). The major lipid component of the brain is cholesterol, espe-
cially in myelin, where it functions as an insulator and enables the efficient transmission of ac-
tion potential signals282. Cholesterol is a post translational modification (PTM) on the C-terminus 
of sonic hedgehog (Shh), where it restricts the spatial diffusion of the morphogen to generate the 
gradients that control vertebrate development in tissues27. Cholesterylation defective mutants of 
Shh show gross mispatterning and embryonic lethality27. Cholesterol sensing, trafficking and 
protein modification are critical to physiology and disease yet their underlying mechanisms are 




Several techniques have been developed to investigate cholesterol and all have limitations42,79. 
Radioactive cholesterol is the most faithful reporter but is limited by speed of detection and can-
not be easily combined with other analyses such as immunohistochemistry (IHC). Indirect meth-
ods to detect cholesterol include enzymatic assays (cholesterol oxidase), cholesterol-binding pro-
teins (the cholesterol-binding region of perfringolysin O or anti-cholesterol antibodies) and poly-
ene dyes that fluoresce when bound to cholesterol (filipin in particular). These methods can suf-
fer from inaccessibility to cholesterol, giving false negative signal, and may have affinity for 
other substances, resulting in false positive signal. Direct visualization methods using fluorescent 
cholesterol analogs provide convenient tools to monitor lipid trafficking42,79, but the fusion of 
large fluorophores to cholesterol may perturb structural features necessary for its biologically ac-
tivity (Figure 32) or interfere with specific cholesterol recognition by endogenous mecha-
nisms27,283. The naturally occurring, intrinsically fluorescent sterol dehydroergosterol (DHE) 
provides a more faithful fluorescent reporter42,79. However, DHE suffers from low quantum 
yield, rapid bleaching and ultra-violet (UV) excitation and emission requiring specialized, UV-
transparent imaging equipment42,79. The two-step bioorthogonal method presented here circum-
vents many of these disadvantages. Cells or animals are labeled with a biologically active choles-
terol reporter, 25-azidonorcholesterol (az-chol) (Figure 30), which has minimal structural change 
and exhibits similar metabolism and distribution to cholesterol in vivo181,284. Following metabolic 
incorporation, az-chol can be reacted with a fluorescent dye best suited to experimental design 
via CuI-catalyzed [3+ 2] azide-alkyne cycloaddition (CuAAC)94, often termed “click chemistry” 
(Figure 30a). This approach allows the use of standard imaging equipment and is easily com-
bined with common analyses and workflows such as IHC. We show that this bioorthogonal tech-
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Figure 28  Cholesterol, 25-azidonorcholesterol (az-chol) and other cholesterol reporters. Accu-
rate and effective reporting of cholesterol requires an analog to 1) be non-toxic to cells; 2) be in-
corporated by cells like cholesterol; and 3) have little or no change in biological activity com-
pared to the native molecule. Most analogues perturb the structural features essential to the bio-
logical activity of cholesterol (a) including: a free 3-hydroxyl (highlighted in red), the planar 
tetracyclic ring system (brown) including the 5(6) double bond (magenta), angular methyl 
groups (green) and the 17-octyl side chain (pink); modifications to these characteristics can 
cause substantially altered behavior; for example 22 and 25 NBD-cholesterol orient themselves 
“up-side-down” with the 3-hydroxyl in the interior of the membrane. (b) 25-azidonor-
cholesterol (az-chol) maintains all these key features, simply replacing methyl 26 with an azide 
(blue). (c) Intrinsically fluorescent cholesterol analogs exhibit similar and nonidentical physio-
chemical behavior to cholesterol; they retain some of the most faithful biological activity. Both 
differ from cholesterol by desaturation of their 7(8), 9(11) and in the case of dehydroergoste-
rol, its 22(23) double bond and an additional methyl group at C24. (d) Spin-labeled 25-
doxylnorcholesterol exhibits biophysical membrane properties that closely match cholesterol, 
demonstrating that the octyl chain can tolerate modification. (e) Many fluorescent cholesterol 
analogs exist; all have significantly modified structure from (a). (f) Multiple crosslinking analogs 








Az-chol was evaluated as a cholesterol analog for photocrosslinking over three decades ago181,284 
and exhibits minimal structural perturbation, as the replacement of a methyl group with an az-
ide maintains the key features80 of biologically active cholesterol (Figure 28). The azide does not 
substantially alter size or hydrophobicity, does not add charge and is biologically compatible. 
Isotope labeling experiments show that az-chol is incorporated into the membranes of baby ham-
ster kidney 21 (BHK-21) cells in place of cholesterol and is sensed by HMG-CoA (3-hydroxy-3-
methyl-glutaryl-CoA reductase, the key regulatory enzyme in the cholesterol biosynthetic path-
way), and causes inhibition of de novo cholesterol synthesis181,284. Incorporation kinetics of radi-
oactively labeled cholesterol and az-chol are nearly identically from 5 to 25 µg/mL (12 – 60 
µM)181. Cells supplemented with cholesterol or az-chol show no significant differences in cell 
growth, DNA, RNA or protein synthesis181. Az-chol does not alter cell morphology after applica-
tion up to 96 hours181. After intravenous injection in rats, az-chol is transported to the liver and, 
as cholesterol, distributes to all subcellular fractions284. Az-chol upregulates acyl-
CoA:cholesterol O-acyltransferase activity in vivo and, as in cells, downregulates HMG-CoA284. 
Esterified az-chol products were also found in the blood and liver284. Az-chol has thus been 




Given the biological activity of az-chol284 and usefulness of chemical reporters and bioorthogo-
nal methods to study protein lipidation93,94,285,286 and lipid trafficking86,287, we synthesized az-
chol181 (Figure 29) and applied it to study cholesterol localization, trafficking and protein modi-
fication (Figure 30, Figure 31 ). We began by verifying az-chol incorporation onto Shh, a known 
cholesterylated protein27. Cholesterylation of Shh is an autocatalytic processing event of the 
45 kDa precursor protein cleaving a 19 kDa N-terminal domain that must also be palmitoylated 
for proper activity27. We metabolically labeled human embryonic kidney (HEK) 293T cells that 
inducibly overexpress Shh288 (293T-Shh) with az-chol and immunopurified Shh. The isolated 
morphogen was then reacted with alkynyl-rhodamine via CuAAC and the modification was im-
aged by in-gel fluorescence scanning (Figure 30b). Because Shh is N-terminally palmitoylated, 
we also labeled 293T-Shh cells with an azido-palmitate reporter (az-15)93,94 as a control for pro-
tein labeling. Both az-chol and az-15 were incorporated onto mature Shh, indicating that az-chol 
correctly reports protein cholesterylation (Figure 30b). Az-15 labeling and rhodamine modifica-
tion alone did not introduce a significant mobility shift, while az-chol labeling induced a notice-
able increase in the apparent molecular weight of Shh (Figure 30b lanes 1 – 3). Dual metabolic 
labeling with az-15 and az-chol imparted a yet further decease in Shh mobility (Figure 30b, lane 
4). Notably, we observe other az-chol-modified proteins in total cell lysates (Figure 31 lanes 1 – 
2), echoing the original autoradiographic evidence that cholesterol modification exists on pro-
teins other than Shh26,27. Az-chol thus serves as an efficient chemical reporter for protein choles-

























Figure 29 Synthesis and characterization of az-chol. (a) Az-chol was synthesized as previously 





Figure 30  25-azidonorcholesterol (az-chol) labeling. (a) Az-chol is first metabolically incorpo-
rated in cell culture or in utero.  Subsequently, az-chol can be visualized by conjugation to rho-
damine through click-chemistry. (b) In-gel fluorescence and Western blot analysis of Shh labeled 
with lipids and their clickable analogs. Both az-chol and az-15 were incorporated onto N-Shh 
and imparted gel mobility shifts. Modification with rhodamine conjugates of az-15 alone show 
the least shift (lane 2, left-hand panel), followed by az-chol (lane 3); their combination imparted 
the greatest apparent increase in molecular weight (lane 4). Due to transfer efficiency, a 20% gel 


















We then evaluated az-chol as a reporter for cholesterol distribution in mammalian cells by fluo-
rescence microscopy. For these experiments we used Chinese hamster ovary (CHO) cells and 
M12 mutant CHO cells that carry a deletion of the NPC1 locus289. Defects in this gene result in 
Niemann-Pick disease type C, an autosomal recessive lipid storage disorder characterized by the 
accumulation of cholesterol in enlarged endosomal-lysosomal storage compartments290,291. These 
filipin-positive perinuclear organelles have been used in NPC disease diagnosis for years292 and 
we sought to compare filipin staining with az-chol imaging. We first verified that application of 
az-chol did not alter fine cell morphology of wild-type CHO or M12 cells compared to choles-
Figure 31 Shh induction and validation of lipid PTMs. Fluorescence pro-
files of 293T cells with and without Shh overexpression. 293T cells and 
Shh overexpressing cells incorporate az-chol and dominant signal is pre-
sent at ~19 kDa and upregulated by overexpression; 293T cells lacking 
Shh show incorporation onto unknown proteins. Different band shifts are
apparent with each modification or combinations thereof. 
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terol by electron microscopy (Figure 32). For fluorescence imaging, cells were metabolically la-
beled with az-chol or cholesterol, fixed (and, in the case of antibody staining, permeabilized with 
1% Tween-20), reacted with alkyne-rhodamine via CuAAC, simultaneously co-stained with fili-
pin and imaged by fluorescence microscopy. Az-chol labeled CHO and M12 cells exhibited 
bright rhodamine fluorescence in intracellular vesicles and cellular membranes; signal was dis-
tributed throughout the cell though attenuated in the nucleus (Figure 33). Rhodamine but not fili-
pin fluorescence was absent in cholesterol-treated samples (Figure 33a and b far right; Figure 
34a). Staining patterns for az-chol and filipin were similar and distinct (Figure 33). Fluorescence 
overlap was extensive (Pearson’s coefficient 0.5 – 0.7), particularly in the cholesterol storage or-
ganelles of M12 cells, but some filipin positive regions (organelles or lipid droplets) showed no 
az-chol signal; the opposite was also true (Figure 33a and b inserts). Particularly notable was la-
beling in the vicinity of the cell membrane: although both techniques labeled the cell membrane, 























Figure 32 Electron microscopy analysis of CHO cells reveals no morphological changes. CHO 
cells (a) and M12 cells (b) show no difference in gross or fine morphology when cultured with 
either cholesterol (top rows) or az-chol (bottom rows) as determined by EM. Note the prominent, 














































Figure 33 Az-chol and filipin labeling of normal and Niemann Pick type C disease model cells 
with and without MβCD cholesterol depletion. False-color representation of (a) normal CHO 
NPC+/+ and (b) CHO M12 NPC-/- cells. Scale bars are 10 µm (main), 2.5 µm (insert). Overlap 
between filipin and az-chol signal is substantial yet different. Some regions are filipin positive 
and az-chol negative; the reverse is also true (a, b). Az-chol signal tended to outline filipin stain-
ing of the plasma membrane (insert arrowheads). Az-chol and filipin both localize to M12 cho-
lesterol-rich lipid droplets but show distinct localization (b). MβCD cholesterol depletion virtual-
ly eliminates az-chol signal but leaves filipin signal for both cells and lipid-rich structures (a, b); 
cholesterol controls show no az-chol labeling (a, b and Figure 34a) and all signal from either 
technique is abrogated with methanol lipid extraction (Figure 34). (c) NPC cholesterol and lipid 










To shed light on the differences between az-chol and filipin staining, we evaluated both imaging 
techniques after lipid extraction and also examined colocalization with subcellular markers. As 
expected, az-chol signal was almost entirely abrogated by cholesterol extraction with methyl-β-
cyclodextran (MβCD) (Figure 33a and b). This contrasted with filipin, where signal remained for 
some CHO cells and many M12 cells, particularly in their lipid storage compartments (Figure 
33a, b). In contrast, general lipid extraction with methanol completely eliminated fluorescence 
staining for both methods (Figure 34b). We examined the subcellular distribution of az-chol and 
filipin with markers for ER (calreticulin), Golgi apparatus (Golgin 97), early endosomes (EEA1), 
lysosomes (LAMP-1) and GM1-gangliosides often found in lipid rafts (cholera toxin B). As pre-
viously reported293, az-chol and filipin stained lysosomal storage compartments encircled by 
LAMP-1 positive vacuolar membranes; these compartments are significantly more pronounced 
in M12 cells compared to wild type (Figure 33c and Figure 35). Notably, multiple compartments 
could be seen with an az-chol rich core surrounded by a filipin positive layer and outlined by 
LAMP-1 signal (Figure 33, insert arrowheads). Az-chol and filipin colocalization with GM1-
ganglioside staining was pronounced in M12 storage compartments (Figure 36), as previously 
observed294. We found minimal az-chol colocalization with other subcellular markers (Pearson’s 
coefficients 0.0 – 0.3), probably reflective of the broad distribution of cholesterol throughout cel-
lular organelles, and az-chol did not appear to alter the localization of subcellular markers (Figs. 
S7 – S9 ). Az-chol thus enables imaging of cholesterol distribution in cells similar to filipin and 







Figure 34  Absence of az-chol signal with cholesterol and elimination of lipid staining with 
methanol lipid extraction.  (a) For CHO or M12 cells cultured with cholesterol, background 
staining was minimal and filipin staining unchanged. (b) Lipid extraction with methanol elimi-






Figure 35 LAMP-1 signal encircles small late endosomal/lysosomal organelles in CHO cells (a) 
and much larger cholesterol storage compartments in M12 cells (b). Cholesterol controls show 








Figure 36 GM1-ganglioside binding FITC-cholera toxin B shows little signal and no pronounced 
colocalization with az-chol in CHO cells (a). Az-chol, filipin and cholera toxin staining was pro-






Figure 37 ER marker calreticulin shows no pronounced colocalization with Az-chol in CHO (a) 






Figure 38 Early endosome marker EEA1 shows no pronounced colocalization with Az-chol in 






Figure 39 Golgi marker Golgin 97 shows no pronounced colocalization with Az-chol in CHO 





We then explored the utility of az-chol for imaging cholesterol distribution in vivo. With only 
~2% of body weight yet nearly a quarter of total cholesterol, the brain is the most cholesterol rich 
organ282. Defects in brain cholesterol homeostasis have dramatic consequences from develop-
ment on and often involve the Purkinje cells of the cerebellum: a hallmark of NPC disease is 
Purkinje cell degeneration282,289 and cerebellar hypoplasia is observed in Smith Lemli-Opitz syn-
drome that results from a defect in the last step of cholesterol synthesis295. Purkinje cells are also 
a major site of neurosteroid synthesis296 and brain cholesterol turnover via cholesterol 24-
hydroxylase282. We thus imaged cholesterol distribution in the cerebellum of a developing mouse 
embryo. Because maternal cholesterol is poorly absorbed and cholesterol is excluded by the 
blood-brain-barrier282, az-chol was directly injected into the lateral ventricle of an E12.5 mouse 
embryo. Sagittal sections at low and high magnification revealed an asymmetrical cholesterol 
distribution (Figure 40). At low magnification, nascent neurons were more intensely labeled, 
likely a reflection of high cholesterol content (Figure 40a, magenta arrowheads). This trend con-
tinued in the inferior colliculus where cells with neural morphology displayed prominent az-chol 
labeling (Figure 40a, labeled IC, magenta arrowheads). In addition, the apical surfaces of the 
cerebellum and inferior colliculus appeared to be enclosed by a cholesterol-rich envelope; the pi-
al surface of the inferior colliculus displayed the same layer (Figure 40a and inserts, white ar-
rowheads). Higher magnification revealed distinct plasma membrane az-chol labeling as well as 
cell polarization with az-chol enriched toward the apical surface (Figure 40b and inserts, magen-
ta arrows); this pattern continued throughout the layers of the pseudostratified neuroepithelium. 
The thick az-chol–rich layer at the apical surface of the cerebellum was pronounced under high 
magnification (Figure 40b and inserts, white arrows). This could be reflective of a “sealant” 
membrane providing proper containment of cerebrospinal fluid (CSF) and might be composed 
140 
 
either of polarized surface cells or an extracellular deposition. Alternatively, the cholesterol-rich 
layer could provide a binding platform for lipophilic hormones and factors circulating in CSF. 






























Figure 40 Cholesterol localization in the developing mouse brain.  Cholesterol was asymmetri-
cally distributed in the cerebellum (C) and inferior colliculus (IC) of the E12.5 developing 
mouse brain. Scale bars are 50 µm (main), 25 µm (insert). (a) Under low magnification, an az-
chol–rich envelope (white arrowheads) surrounded the apical surface (AS) of the cerebellum and 
inferior colliculus. These apical surfaces interface the cerebrospinal fluid (CSF) filled ventricles 
(V). The pial surface (PS) of the inferior colliculus also exhibited an exterior az-chol band. Az-
chol signal was pronounced in nascent neurons (magenta arrowheads; see also inserts), likely re-
flecting high cholesterol content. Rhodamine signal was absent in littermate controls. (b) Higher 
resolution revealed the structure of the thick apical envelope in the cerebellum (white arrow-
heads). Scale bars are 10 µm (main), 2.5 µm (insert). Az-chol distinctly labeled plasma mem-
branes of neural progenitors and tended to show apical localization (magenta arrowheads). Api-





























Cholesterol has long been difficult to image. External factors other than cholesterol can alter the 
results of indirect assays: cholesterol oxidase results depend on membrane composition and loca-
tion, fixing technique and a host of other aspects79,297. Likewise, perfringolysin O derivatives on-
ly bind regions with high (>20-25 mol%) cholesterol content and may be influenced by mem-
brane properties79. Echoing the results here, filipin has been previously reported to yield false 
positive signal after cholesterol predepletion with MβCDs and can report the opposite of perfrin-
golysin O staining79. Filipin false negatives have also been observed for multiple organelles297, 
depending on clathrin content298, and in smooth muscle plasma membrane299. The persistence of 
filipin signal after MβCD but not methanol for normal and M12 cells (above and Figure 34) in-
dicates filipin has substantial lipid affinities outside of cholesterol. 
 
Direct imaging of cholesterol has also presented challenges. All but a few cholesterol analogs 
have significant structural changes that perturb key features essential to the biologically activity 
of cholesterol42,71,79 (above). Some of these changes radically alter cholesterol behavior, resulting 
in an “upside down” orientation (with the free 3-hydroxyl pointing into the membrane interior) 
or disrupting cholesterol-induced phospholipid membrane condensation42,68. Intrinsically fluo-
rescent sterols like DHE and cholestatrienol, despite their similarity in biological behavior, are 
limited by their requirement of UV compatible instrumentation and may face a high background 
from tissue autofluorescence. The two-step labeling approach described here involves the meta-
bolic incorporation of a biologically active cholesterol reporter, az-chol, which has minimal 
structural perturbation compared to cholesterol, traffics like it and is nontoxic in vivo. Subse-
quently, fluorescent dyes are installed using bioorthogonal ligation methods for direct imaging. 
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This approach can be applied from a single protein to a whole organism and represents an excel-
lent option for rapid, easily accessible and multimodal cholesterol imaging. We anticipate 
bioorthogonal cholesterol reporters like az-chol will aid in the study of cholesterol function in 





The identification of a new class of histone PTMs raises many interesting questions about bio-
logical significance including the mechanism of modification, stability, dynamics and regulation, 
effect on structure and chromatin stability, as well as effect on histone localization.  These ques-
tions represent exciting possibilities for future experimental work. 
Validation of in-vivo modification 
As illustrated in Figure 21, of the three potential mechanisms for fatty-acylation of histone H3, 
the possibility of in vivo chemical modification is unlikely due to the low concentration of acti-
vated fatty acids resulting from acyl-carrier binding proteins (ACBPs). In addition, the chemical 
inaccessibility of intact histones precludes reaction. However, there exists the chance that acyla-
tion occurs as a post-lysis artifact, when both ACBPs and nucleosomes are denatured exposing 
both the formerly unreactive cysteine and releasing activated CoA esters. Thus, this possibility 
should be examined prior to other research. 
Validation of in-vivo modification by manipulation of activated CoA and sulfhydryl reactivity  
Two straightforward experiments can quickly answer this answer. In the first approach, the reac-
tion between endogenous activated fatty-acid ester and free thiols is chemically modified. After 
metabolic labeling with alkyne or azido palmitic acid, cells can be split into three equal fractions. 
One fraction will be subject to rapid lysis (Polytron) in the presence of a large excess (e.g.100 
mM) of a reduced thiol such as mercaptoethanol or cysteamine, providing a sink for activated 
fatty acids. As the total cellular concentration of activated acyl-CoA esters lies in the range of 5 – 
146 
 
160 µM 300, this 600 – 20,000-fold excess will substantially reduce if not prevent post-lysis fatty-
acylation. The second fraction will be likewise lysed in an excess of a thiol capping reagent, such 
as iodoacetamide, also in high concentration (e.g. 50 mM). Under such conditions, newly ex-
posed thiols are likely to be immediately capped, rather than potentially acylated. The third frac-
tion serves as a control and can be lysed without change from previous experiments. After lysis, 
thiol, thiol capping reagent and any remaining CoA intermediates will be removed by simple 
methanol precipitation; previous experiments indicate click chemistry is unaffected after either 
thiol capping or after reduction with mercaptoethanol, as long as such reagents are removed by 
precipitation. Following protein pellet resuspension and the addition of cleavable affinity tag, the 
capture and retrieval can be repeated as previously. Parallel Western blot analysis will reveal if 
histone H3 fatty-acylation is reduced or eliminated by excess free thiol or thiol capping com-
pared to control levels. This approach offers the advantage that cellular concentrations of both 
small molecules (excepting added reagents) and proteins remain unmodified. Both thiol capping 
and a thiol sink represent a mechanism to control post-lysis fatty-acylation, should it be occur-
ring. 
Validation by addition of marked activated CoA-palmitate 
Mirroring this approach but monitoring the presence rather than lack of reaction, a potential 
chemical modification can be determined by the inclusion of a marked activated fatty acid, either 
radioactive or stable isotope, or the addition of a marked protein, either bearing a tag or likewise 
isotopically marked, which is present during lysis. In the first case, [13C]-palmitic acid available 
from multiple suppliers can be activated as described 301 and added at physiologically relevant 
concentrations (e.g. 5, 50 and 100 µM) to cells during histone extraction lysis. Isolated histones 
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can then be dually digested sequentially with trypsin and GluC, which will produce a peptide 
TNLCAIHAK of monoisotopic mass 969.507 when unmodified. This size is well within the 
range of MS peptide analysis. The relatively uncomplicated protein composition of a histone ex-
traction allows infusion and monitoring of a particular m/z, circumventing the possibility that 
lipidated peptides are lost on a reverse phase column. Alternatively, a different stationary phase 
such as a HILIC (hydrophilic interaction liquid chromatography) column which elutes similar to 
a normal phase could be employed. In either case, the m/z of the peptide alone, likely as a doubly 
charged species, and the peptide modified by palmitic acid, palmitic acid analogs, or isotopically 
tagged palmitic acid can be followed. The reaction of added activated esters resulting in [13C]-
palmitoylated histone peptides suggests a post-lysis artifact. However, to properly interpret re-
sults, this experimental setup requires exact knowledge of the concentration of endogenous acti-
vated esters as the two and a half log variation in concentration will substantially change extent 
of reaction: observation of a newly modified species at 100 µM might not reflect the mechanism 
of palmitoylation if endogenous concentrations are 10 µM or less. 
Validation by addition of marked H3 
Because exact endogenous concentration of activated fatty acids may be difficult to ascertain, a 
more straightforward approach is the addition of tagged histone H3 during lysis. This tag can be 
genetic, such as the his-tagged H3 variants employed here, or it could be marked by stable iso-
tope labeling. The most interpretable data would be generated by addition of a purified histone 
and the myc-his-tagged H3 variants employed here provides a convenient mechanism of purifi-
cation (IMAC). Alternatively, an isotopically marked H3 could be purified by histone extraction 
and immunoprecipitation (Figure 13). Whole cell lysates from co-lysis of cell pellets of either 
148
 
genetically or isotopically marked, together with cells metabolically labeled with clickable pre-
cursors, represents another possible approach. However, in this case the levels of small molecule 
are uncertain, and competing, possibly differentially labeled, activated fatty acid esters could 
complicate results. While concentrations could be assumed to be equivalent in cells cultured 
simultaneously, e.g. with the same concentration of [13C]-lysine and [12C]-lysine, the fact that al-
kyne-fatty acids in particular modify fatty acid metabolism makes this assumption precarious. 
Additionally, for genetically tagged, overexpressed H3, the relative protein concentrations will 
be unknown and are likely difficult to control. 
 
In all configurations, the lysis buffer would contain a known quantity of histone, preferably 
matched to endogenous levels (equalize by Western blotting). After a native, non-reducing gel to 
check that the cysteine is still free (no H3 dimers), the purified protein would be dissolved in the 
same volume of lysis buffer and the cells lysed with this solution as before. The check for disul-
fide status could also be done on purified proteins via a colorimetric assay (Ellman’s reagent) but 
is essential to ensure free sulfhydryls due to the lack of disulfide reactivity. Alternatively, the 
same number of metabolically labeled wild-type cells and genetically tagged, H3-expressing 
cells could be copelleted and lysed. Analysis can be by Western, looking for H3 itself (which in 
the myc-his-H3 is shifted by the myc-his tag), by an antibody against the myc epitope or by both 
antibodies, simultaneously, sequentially or in two membrane stripes. In the case of myc-his-H3s 
used here, after purification of palmitoylated proteins as described from native cells lysed in the 
presence of myc-his-H3s, the presence of a myc tag from clickable fatty acid analogs indicates 




A final experimental setup would examine the presence of newly (chemically) palmitoylated, 
isotopically marked peptides. In this arrangement, lysis by histone extraction would take place 
with simultaneous inclusion of purified isotopically marked histone H3, for example labeled with 
[13C]-cysteine, again in a roughly equivalent concentration to endogenous levels). Chemically 
modified, isotopically marked peptides can then be detected after codigestion with trypsin and 
GluC as described above. For all cases in which histone extraction is used, it must be noted that 
HPLC separations of histones are well established. Thus, after knowing the chromatographic 
properties of a palmitoylated standard, HPLC can allow for both enrichment as well as detection. 
Such a standard can be made by incubating reduced, purified H3 with a large concentration of 
CoA-palmitate (e.g. 0.1 – 1 mM) using e.g. methyl-beta-cyclodextrin and/or organics to maintain 
solubility; the established HPLC separation methods allow purification for additional experi-
mental investigation described below. 
Future experimental analysis of palmitoylated H3 
After verification that histone modification is not an artifact of post-lysis chemical reaction, ex-
periments can address the possible influences of fatty-acylation on nuclear location; dynamics 
and regulation of histone palmitoylation throughout the cell cycle and relationship to other his-
tone PTMs; mechanism of modification; effect on nucleosome stability; effect on nucleosome 





The effect of palmitoylation on subnuclear localization can be easily addressed in two experi-
mental approaches. First, immunohistochemical techniques employing an anti-myc antibody can 
examine the localization of myc-his tagged H3 and the tagged C→A mutant. Various cell lines 
can be transfected as described, protein allowed to be expressed for e.g. 12 hours, fixed, permea-
bilized, and visualized with anti-myc antibody. Predigestion with a nuclease (e.g. Benzonase) 
may be required for optimal signal and neighboring untransfected cells serve as negative con-
trols. This approach, while direct, may suffer from limited selectivity due to the low stoichiome-
try of modification. To combat this limitation, as nucleosomal histones have been shown to 
translocate across cell membranes into the nucleus302, exogenously supplied H3 – both fully 
palmitoylated and reduced – can be applied externally. Nuclear trafficking of purified, epitope-
labeled histone H3 can be imaged by IHC. Alternatively, the fatty-acylated and unmodified H3 
can be marked with a fluorophore by either genetic means (e.g. GFP) or chemical reaction (e.g. 
dansyl chloride, sulfo-NHS-rhodamine) and imaged during and after incorporation. This ap-
proach allows live imaging but the behavior of the modified histone must be validated by com-
parison to a less perturbed system. One of the best approaches for a validation would be applica-
tion of an H3 variant palmitoylated in vitro with a clickable analog to cells grown otherwise 
without clickable analogs. Visualization with the click reaction in combination with subcellular 
markers would then reveal localization, such as preferential association with the nuclear enve-
lope. Ideally, this technique will also be combined with analysis of cell cycle as described below. 
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Cell cycle dynamics of H3 palmitoylation and palmitoylation relationship to other histone PTMs  
Many histone PTMs vary throughout the cell cycle and this may also be the case for histone H3 
palmitoylation. The possibility can be easily examined through a combination of cell synchroni-
zation and metabolic labeling; by analyzing both state of protein modification and cellular locali-
zation, insight can be gleaned as to the possible cycle-dependent effects of palmitoylation on 
protein trafficking. Analysis of time points selected to fall within each point of the cell cycle 
should be performed after double thymidine block, thymidine-nocodazole block or serum starva-
tion. In each case, cells can be metabolically labeled with alkyne or azido fatty acids for a con-
stant incubation of 1-12 hrs, likely optimally at 4-6 hrs, before the sample is lysed. Samples can 
then be parallel purified for fatty-acylated proteins and analyzed by Western blotting. Alterna-
tively, purified samples may be analyzed by mass spectrometry after digestion with various 
combinations of proteases both for relative abundance and information of PTMs present on pal-
mitoylated histone peptides. This could be done in a label-free manner, but would be best per-
formed by protein level labeling with iTRAQ. Following iTRAQ labeling, samples of various 
time points can be combined and purified in a single purification. Labeled proteins can subse-
quently be digested and analyzed in one run, eliminating sample preparation variability, and 
mass spectrometric analysis would yield information of both the relative abundance and identity 
of accompanying, possibly varying PTMs throughout the cell cycle. The analysis of co-occurring 
PTMs is of course also possible without cell synchronization, however it makes the most sense in 
that context. Antibodies to various histone PTMs and Western blotting of purified palmitoylated 
proteins represent an alternative method to detect combinations of PTMs linked to histone pal-
mitoylation. For both detections, dynamics would be reflected by a change in relative pal-
mitoylated abundance throughout various time points in the cell cycle. In order to properly inter-
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pret the results, a required control is knowledge of total H3 levels; this can be obtained by a 
Western of input material before fractionation or likewise analysis by MS and iTRAQ signal af-
ter digestion.  
Mechanism of modification 
After ruling out chemical modification during lysis, the remaining possibilities of autocatalytic 
modification and enzyme-mediated fatty-acylation can be tested with two simple experiments. 
While autocatalytic modification is unlikely, a consequence of the known buried and unreactive 
state of H3 sulfhydryl in assembled nucleosomes, it cannot be ruled out a priori: auto-
modification might for example occur in rout to the nucleus prior to quaternary structure. To ex-
perimentally address this possibility, purified H3 (IMAC purification for his-tagged H3 variants, 
immunoprecipitation or HPLC from native sources, or a combination of these strategies) can be 
incubated with activated palmitoyl-CoA esters of either radiolabeled or clickable fatty acids in 
the presence and absence of acyl-carrier binding protein. In the former case, detection is by auto-
radiography and in the latter, in-gel fluorescence after click chemistry with a fluorophore. In the 
absence of ACBP, reaction at high (e.g. mM levels) of activated ester is expected; such levels are 
unreflective of cellular condition, reflect simple chemical modification and serve as a positive 
control. Note that solubility in the absence of ACBP may be an issue and may require the pres-
ence of MBCD.  Self-palmitoylation such as the loading step of DHHC-PATs takes place in the 
presence of fatty-acid binding proteins and palmitoylation of H3 in the presence of ACBP at rea-
sonable concentration (e.g. 5 – 250 µM) suggests autocatalytic modification. In this case, further 
studies of enzyme kinetics are warranted. For both autocatalytic and enzyme-mediated modifica-




If autocatalytic modification is absent, enzymatic modification by DHHC-PATs can be assayed 
by the co-overexpression of H3 variants with DHHC-PATs (in pools or individually); an empty 
vector transfection serves as a negative control. Detection is as above, either click chemistry and 
subsequent in-gel fluorescence or autoradiography, both after metabolic incorporation of respec-
tive analogs. The simplest readout is an SDS-PAGE gel looking for a H3 signal noticeably up-
regulated by the cotransfection of one or more PATs. Alternatively, a more precise result can be 
obtained by isolation of fatty-acylated proteins, followed by Western detection as described. In 
the case, the same anti-myc can be used for detection, or as described above, alternatively the an-
ti-H3 antibody looking either for the shifted histone signal, or the endogenous signal, which in 
the presence of an active DHHC-PAT would also be expected to increase in abundance. The pos-
sible identification of a PAT modification of H3 begs additional questions such as the location of 
modification and its timing, questions which would be addressed by experiments. 
Effect of H3 palmitoylation on nucleosome composition and stability 
H3 palmitoylation might modify the stability of histone octamers, possibly strikingly: as the bur-
ied cysteines already form a region of hydrophobic yet reversible259,260 hydrophobic interaction, 
palmitoylation of one or both H3 cysteines could foster an especially stable interaction, as has 
been observed in and which is required for activity of Bet3303,304. This interaction could be be-
tween two palmitate residues, or alternatively between a native and modified H3. Experimental 
analysis of these questions requires purification of H3 and other core histones, which is most eas-
ily done in an appropriate scale by HPLC261 from cell lines or native sources. Chicken erythro-
cytes have historically been heavily employed and protocols employing that protein source have 
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been developed for nucleosome reconstitution305 and crystallization247. In addition, because a 
C→A mutant can be generated in vitro by Raney nickel dethiolation of cysteine306, this likely 
represents the best material for biochemical experiments. 
 
After purification of core histones from chicken erythrocytes, dethiolation of a portion of H3, 
palmitoylation of another portion of H3 as described above under “Validation by addition of 
marked H3,” and validation of identity, purity and extent of reaction (SDS-PAGE and mass spec-
trometry or Western blotting or both), core histones can be reconstituted by established methods 
305. Histone octamer reconstitution can be validated by gel filtration chromatography, analytical 
centrifugation and native non-reducing gels. Reconstitution of the nucleosomes with pal-
mitoylated H3 may require experimental optimization such as alterations in chaotrope (thiourea 
or guanidinium chloride might for example be substituted for urea), changes in dialysis such as 
times, chaotrope concentrations, temperatures or chaotrope substitutions; these experimental 
modifications must be empirically determined. 
 
Reconstitutions should be attempted with native, fully palmitoylated and dethiolated H3. In addi-
tion, a reconstitution should be performed with an equimolar mix of palmitoylated and native or 
dethiolated H3 to addresses the preference of acylated H3 within the environment of the nucleo-
some. To determine this preference, nucleosome subunits should be fully chemically cross-
linked307, the different variations of nucleosome composition isolated by HPLC and the sulfhy-
dryl content of fractions determined (e.g. Ellman’s reagent). While a somewhat heterogeneous 
set of products is expected due to crosslinking, a predominant fraction with one free cysteine per 
262 kDa nucleosome reflects preference of a palmitoylated H3 for native H3. In conjunction 
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with this approach, H3 modified with a clickable palmitic acid analog can be reacted with a 
fluorophore and the molar equivalent of fatty acid per fraction determined by absorbance or fluo-
rescence; specific radioactivity can be employed in an analogous manner. 
 
Octamer stability of reconstitutions from native, dethiolated and fatty-acylated octamer can most 
easy be compared by non-reducing urea gradient gels; this provides a direct, side-by-side com-
parison of dissociations. Alternatively, analytical ultracentrifugation of octamer with different 
concentrations of chaotrope or salt can determine the relative equilibrium of subunit and assem-
bled nucleosome. Finally, reconstituted octamers can be combined with DNA308 and the resulting 
pellet exposed to gradually increasing salt concentrations309. Decreased stability results in the in-
creased release of histone monomers into the supernatant at lower salt concentrations (gel). 
Effect of H3 palmitoylation on chromatin and nucleosome structure 
The possibly different chromatin structure resulting different states of H3 acylation in nucleo-
somes can be explored by many techniques such as digestion, gel-shift and supercoiling assays. 
However, such reconstitution is subject to influence by a wide variety of variables including 
DNA:histone ratio, possibly ATP-dependent assembly machinery and others310. These parame-
ters must be empirically explored. At the single nucleosome level, established crystallization 
conditions can be attempted after successful reconstitution in either the presence or absence of 




Palmitoylated H3 protein and DNA sequence selectively 
In addition to possible effects that altered nucleosome structure could have overall on chromatin, 
H3 palmitoylation might affect the proteins which bind octamers. Changes in both preferred pro-
tein binding partner and sequence can be determined by combining metabolic labeling and puri-
fication of lipidated proteins with a myc-his tagged H3. Both analyses begin as described for the 
identification of palmitoylated H3 with overexpression and simultaneous metabolic labeling. A 
modified chromatin IP (ChIP) is employed for identification of DNA binding sites in which cells 
are fixed in formaldehyde, nuclei are isolated and disrupted followed by micrococcal nuclease 
digestion to nucleosomes311. These crosslinked nucleosome are subjected under denaturing con-
ditions (urea and/or SDS) to serial isolation of the his-tag (IMAC) followed by capture of pal-
mitoylated proteins as described. The flow through must be examined to determine the absence 
of biotinylated, palmitoylated proteins for the accurate comparison of differences in binding se-
quence of H3 modification. Both unmodified H3 proteins of the flow-through and the Na2S2O4 
eluted, palmitoylated H3 can be matched in protein concentration and subjected to protease K 
digestion. DNA is then extracted (chloroform/methanol), gel purified and sequenced to reveal 
differences in DNA sequence preference311. 
 
Proteins interacting with H3 of different states of fatty-acylation can be determined in an analo-
gous manner but leaving protein not DNA. In this case, chromatin is prepared as above but cross-
linked with a cleavable crosslinker such as BSOCOES (base cleavable), DSP, DTSSP or DTBP 
(thiol cleavable; see caution below), or DST (periodate cleavable) in place of formaldehyde. Af-
ter denaturation (SDS/urea), benzonase is used to fully digest DNA. IMAC under denaturing 
conditions can then isolate his-tagged H3 and palmitoylated H3 is subsequently purified on 
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beads as described but not eluted with Na2S2O4. Rather, the release agent for the cleavable cross-
linker is applied, releasing proteins bound to palmitoylated H3. Similarly, the flow through from 
fatty-acylated H3 purification can be re-applied to another IMAC column and the bound, cross-
linked proteins released by the necessary cleaving reagent. Note that while sodium dithionite is 
reasonably tolerant to sulfhydryls (analysis of labeled proteins by reducing SDS-PAGE is possi-
ble), storage of samples in BME, even at – 80 C, resulted in loss of signal, indicating that elution 
with thiol will require optimization of time and concentration on model systems. Likewise, 
IMAC is sensitive to pH and the redox state of nickel; conditions will require optimization. The 
eluted H3 crosslinked fractions can then be analyzed by mass spectrometry (in-gel or in-
solution). 
Analysis of in-vivo effect 
After H3 palmitoylation has been verified to take place in vivo and studied in vitro, the modifica-
tion can be studied in vivo in mice. This will involve either kockin of H3.1, H3.2 and H3.3 each 
bearing C→A mutations, followed by subsequent crossing, or kockout of two of the three fol-
lowed by crosslink with the remaining mutant. According to the Mouse Genome Database, no 
knockouts exist for any H3 variant, and the first experiment would involve determination of via-






Like science upon which they are based, these new techniques represent stepping stones and the 
most interesting work lies ahead: what is the function of histone palmitoylation and what else is 
ubiquitous, ancient, essential yet potentially harmful cholesterol doing? Many histone PTMs 
have no phenotype; would this one? Here at Rockefeller the Allfrey lab discovered this buried 
histone residue to be opened up during active transcription260. Could palmitoylation serve to an-
chor necessary protein complexes – more or less the major role lipids serve on proteins – during 
this process? Likewise, this work discovered many ribosomal proteins to be lipidated, work later 
validated by the Freeman lab, and revealed fatty-acylation of may multi-protein complexes. 
What else have we been missing in the role of lipids to organize cellular processes? It will be ex-
citing to see what biology falls out of unbiased screens such as this one, and this study is another 
stark reminder of how much sample preparation influences results. Lipids and in particular cho-
lesterol seem to be prominently involved in factors essential to the development of organisms 
and to me, they have always seemed to be a sort of a “gentle anchor”; this is particularly appar-
ent in Shh distribution of cholesterylation null mutants. With the ability to visualize the presence 
and distributions of lipidated proteins, the door opens to the study of such low-level factors (as 
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